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ABSTRACT 
 
STUDIES TOWARD THE SYNTHESIS OF NODULISPORIC ACIDS A AND D 
Jason E. Melvin 
Amos B. Smith, III 
 
 
 The dissertation herein presents efforts toward the synthesis of the potent insecticidal indole 
diterpenes, nodulisporic acids A and D. Chapter one details the isolation of the nodulisporic acid 
family of compounds by Merck, as well as the efforts at Merck to utilize (+)-nodulisporic acid A as 
a veterinary medicine lead structure. Further, chapter one reviews the previous strategies 
employed by the Smith group toward the syntheses of the nodulisporic acid family. Lastly, the 
development of a modular and highly convergent strategy to access the nodulisporic acids 
exploiting a one-pot tandem Buchwald-Hartwig/Heck cascade to generate a common central 
indole core is described.  
Chapter 2 will describe the development of a revised synthetic strategy to access the required 
western hemisphere chloroindoline for the synthesis of nodulisporic acid A. 
Chapter 3 outlines the synthesis of the eastern hemisphere common to both nodulisporic acids A 
and D. The development of a new strategy for the construction of the C-3 and C-12 stereocenters 
now allow for the synthesis of sufficient quantity of the eastern hemisphere for coupling studies. 
Chapter 4 describes the development and implementation of an Enders alkylation and a Stille-
Kelly coupling to generate the western hemisphere of nodulisporic acid D. 
Chapter 5 disclosed our results attempting to implement the one-pot tandem Buchwald-
Hartwig/Heck cascade to access nodulipsoric acids A and D. Furthermore, future plans for the 
further development of the Buchwald-Hartwig/Heck(Barluenga) cascade tactic are described. 
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CHAPTER 1.   (+)-NODULISPORIC ACID A AND                               
(–)-NODULISPORIC ACID D – BACKGROUND 
1.1. THE ISOLATION AND EVALUATION OF BIOLOGICAL ACTIVITY OF 
THE NODULISPORIC ACID FAMILY 
 
1.1.1. ISOLATION AND STRUCTURAL DETERMINATION BY MERCK 
!
  In 1997, the Merck Research Laboratories reported a novel insecticide, (+)-
nodulisporic acid A (1.1), isolated from the fungus Nodulsporium sp.1  Nodulisporic acid 
A (NSAA) is a potent indole diterpene that bears resemblance to many other previously 
isolated indole terpene compounds (Scheme 1.1).2 They all contain a central indole 
unit, fused to a common tricycle eastern hemisphere.  
Scheme 1.1 Indole Terpene Natural Products 
!
!
!
!
!
!
!
!
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(+)-nodulisporic acid A, and the absence of the tertiary hydroxyl group at C-9, that is 
common in many of the other indole terpenes. When compared to the shearinine and 
janthritrem families of molecules, the western hemisphere is the same, but with the ring 
fusion inverted.  
Nodulisporic acid A (+)-1.1 is comprised of 8 fused rings, with the fused tricyclic core 
standing out as a unique feature.  Workers at Merck performed exhaustive studies to 
assign the structure of (+)-nodulisporic acid A. To confirm and fully elucidate the 
structure of (+)-nodulisporic acid A, COSY, TOCSY, HMBC, HMQC and INADEQUATE 
NMR studies were utilized to determine the carbon connectivity through the fused ring 
systems (Scheme 1.2).  
 Scheme 1.2. 2D NMR Studies to Determine the Carbon Connectivity of (+)- 
Nodulisporic Acid A (NSAA) 
 
ROESY and NOESY experiments in particular were used to determine the relative 
stereochemistries of the eastern and western hemispheres. The Merck group hoped 
that X-ray crystallography would permit determination of the absolute stereochemistry 
of (+)-nodulisporic acid A. In order to generate an X-ray quality crystal, reaction of the 
nodulisporic acid A methyl ester with bromobenzoyl chloride furnished the C-7 
benzoate. The crystal of the nodulisporic acid A derivative permitted determination of 
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the relative stereochemistry, but the quality of the crystal was not sufficient to permit 
assignment of the absolute stereochemistry. To determine the absolute 
stereochemistry, Mosher ester analysis3 was applied at the C-7 hydroxyl group.  
1.1.2. DEGREDATION OF (+)-NODULISPORIC ACID A (NSAA) 
!
 During the course of the isolation and NMR experiments, the Merck group found that 
NSAA is sensitive to both light and oxygen, degrading to two major compounds 
(Scheme 1.3). The first degradation pathway entails oxidation of the highly strained 
central indole ring, which was observed to undergo oxidative cleavage of the fused ring 
system to give the 8-membered ketoamide ring. The stereochemistry of the dieneoate 
was also found to undergo isomerization during NMR experiments in CD3CN. 
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1.2. PROPOSED BIOSYNTHESIS OF (+)-NODULISPORIC ACID A  
1.2.1. PRECURSOR STUDIES 
 
 In 2001, Merck reported the successful elucidation of the biosynthetic pathway for the 
synthesis of (+)-nodulisporic acid A.4 The workers at Merck were able to access 13C 
enriched (+)-nodulisporic acid A utilizing 2-13C-acetate 1.7, that is known to be 
metabolized via the mevalonate pathway (Scheme 1.4). The mevalonate pathway is 
essential for the conversion of acetate to isopentenylpyrophosphate 1.8, which is the 
crucial intermediate in the synthesis of all terpenoid natural products.  
Scheme 1.4. Mavalonate Pathway 
 
Using this strategy, each isoprenyl group that is incorporated into the molecule would 
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To determine if the central indole was derived from tryptophan, 13C enriched tryptophan 
was prepared, as has been employed previously to determine the origin of the indole in 
similar molecules. No 13C incorporation was observed; Merck then turned their attention 
to the possibility that anthranilic acid was the indole precursor. This work demonstrated 
that the indole ring is actually generated from anthranilic acid and ribose.  
1.2.2. ISOLATION OF RELATED MEMBERS OF THE NODULISPORIC ACID 
FAMILY 
!
During the isolation and biosynthetic studies, related members of the nodulisporic acid 
family of molecules were isolated, giving clues about the biosynthetic pathway 
(Scheme 1.5).5 The simplest member of the family is (+)-nodulisporic acid F (1.12), 
which is comprised of only the central indole ring and the eastern hemisphere. 
Nodulisporic acid D [(–)-1.11] was also isolated, whereas the western hemisphere is 
now appended. It is believed that both of these compounds are intermediates on the 
pathway to (+)-nodulisporic acid A (1.1).  
Scheme 1.5. Members of the Nodulisporic Acid Family 
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Merck proposed that beginning with (+)-nodulisporic acid F (1.12), the indole ring is bis-
prenylated to furnish nodulisporic acid E (1.13, Scheme 1.6). Following bis-prenylation, 
the isoprenyl group is then oxidized twice and in turn undergoes cyclization to form the 
bicyclic western hemisphere. Subsequently, the allylic position of the side-chain is 
oxidized and eliminated to provide (–)-nodulisporic acid D (1.11). Prenylation of the 
indole would then lead to nodulisporic acid C (1.14). After an oxidation, cyclization onto 
the nitrogen of the indole and elimination would complete the synthesis of (+)-
nodulisporic acid A (1.1). 
 Scheme 1.6. Nodulisporic Acid A Biosynthetic Pathway 
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1.3. BIOLOGICAL ACTIVITY AND MEDICINAL CHEMISTRY STUDIES 
1.3.1. BIOLOGICAL ACTIVITY OF (–)-NODULISPORIC ACID A 
 
Shortly after isolation, (–)-nodulisporic acid A (1.1) was discovered to have very 
promising biological activity against fleas. In fact, in some studies, (–)-nodulisporic acid 
actually performed better than the well-known, very potent, insecticide, ivermectin 
(1.15)6. Both ivermectin and (–)-nodulisporic acid A were subsequently determined to 
have similar modes of action.  They both selectively target an insect specific glutamate 
gated chloride channel. Their interaction with the chloride channel disrupts the normal 
trans-membrane electrolyte potential, leading to cell death, mainly in neurons. 
Nodulisporic acid A was also shown to be more selective than ivermectin, possibly 
hitting only a subset of channels that ivermectin is active against. However, in 
analogous GABA-gated chloride channels, ivermectin is still highly active, while 
nodulisporic acid A shows little to no activity.  
Scheme 1.7. Potent Insecticides 
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1.3.2. MEDICINAL CHEMISTRY STUDIES 
!
Following the promising results of the initial biological studies, Merck decided to 
undertake a medicinal chemistry campaign to determine the key components to the 
noduliporic acid A pharmacophore. 
 Scheme 1.8. Pharmacophore 
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significantly less active compounds in the flea assays (Scheme 1.8). More interesting 
however, the Merck group found that a large range of modifications were permissible at 
the dienoate side-chain, the latter prepared by the oxidative cleavage of the dienoic 
acid to aldehyde 1.17 (Scheme 1.9).7 The aldehyde was then employed as a handle to 
construct analogs with novel, unnatural side chains. Analogs with simple substitutions, 
such as conversion of the carboxylic acid to a dimethyl ester, or more complex 
substitutions, such as thiazol 1.18, revealed increased potency against ticks.8 
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 Scheme 1.9. Medicinal Chemistry Aldehyde Intermediate and Thiazole Analog 
 
 
1.4.  THE FIRST GENERATION SMITH SYNTHESIS FOR (+)-NODULISPORIC 
ACID A 
1.4.1. APPLICATION OF THE SMITH–MODIFIED MADELUNG INDOLE   
SYNTHESIS 
The Smith group has had a long-standing interest in the synthesis of indole terpene 
natural products.9,!10,11 The group has successfully demonstrated how the application of 
a modified Madelung indole synthesis can be a powerful strategy for the construction of 
very complex natural products. The original Madelung indole synthesis typically 
proceeds by treatment of an acylated toluyl aniline with strong base at high 
temperatures to generate the desired indole (Scheme 1.10).  Extremely harsh reaction 
conditions are required to generate the dianion intermediate and in turn eliminate water 
to achieve aromatization to the indole.  
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 Scheme 1.10. Madelung Indole Synthesis 
!
These conditions would hardly be applicable in the context of complex natural product 
synthesis. The Smith group recognized that if the dianion derived from a 2-alkyl-N-
trimethylsilyl aniline were treated with an ester, the resulting intermediate could undergo 
an aza-Peterson olefination, at lower temperatures than a typical Madulung indole 
reaction, and then tautomerize to generate the indole under much milder conditions.  
 Scheme 1.11. Smith Modified Madulung Indole Synthesis 
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The Smith modified Madelung indole formation/union strategy would go on to be used 
in many indole natural products in the Smith Laboratories. One case that truly highlights 
the high degree of complexity that can be successfully incorporated into the coupling 
fragments is the synthesis of penitrem D (Scheme 1.12).10 In this case, aniline fragment 
1.31 was first metalated with n-BuLi. The lithium anion of the aniline was then trapped 
as the tetramethylsilyl aniline using chlorotetramethylsilane. Both the benzylic position 
and the TMS aniline were then deprotonated utilizing sec-BuLi to generate the dianion. 
The dianion intermediate was in turn reacted with lactone 1.32 to generate the aza-
Peterson olefination precursor. Treatment with silica gel completed construction of the 
highly functionalized indole 1.33 in a very good yield via an in situ aza-Peterson 
olefination, which was then carried forward to complete the total synthesis of pentram 
D. 
 Scheme 1.12. Penitrem D Indole Coupling Strategy 
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1.4.2. RETROSYNTHETIC ANALYSIS OF (+)-NODULISPORIC ACID D: 
APPLICATION OF THE SMITH MODIFIED MADELUNG INDOLE 
SYNTHESIS  
!
Taking inspiration from successful generation of the highly functionalized indole 
intermediate of penitrem D, the Smith group turned their attention to applying the 
coupling strategy to other complex indole terpenes. The first generation strategy taken 
by the Smith group for (+)-nodulisporic acid A was inspired by the proposed 
biosynthesis (Scheme 1.13).   
 Scheme 1.13. Biomimetic Retrosynthetic Approach to (+)-Nodulisporic Acid A 
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The medicinal chemistry studies on (+)-nodulisporic acid A done at Merck suggested 
that the dienoic acid could be installed at the end of the synthesis. As there was no 
precedent for the synthesis of the highly strained CDE fused tricyclic core, the first 
strategy required focus on generating the full ring system of NSAA without ring D. Then, 
as in nature, the D ring would be generated from intermediate 1.34, which contains all 
of the remaining carbons of the fused ring system of (+)-nodulisporic acid A. It was 
envisioned that indole 1.34 could be constructed utilizing the Smith modified Madelung 
indole synthesis from aniline 1.35 and lactone 1.36.  
 
1.4.3. THE SYNTHESIS OF (+)-NODULISPORIC ACID F: A MODEL STUDY 
 
To determine if the indole coupling strategy might be viable to access the nodulisporic 
acid family of natural products, the Smith group reasoned that the coupling strategy 
should first be attempted on one of the biosynthetic precursors to (+)-nodulisporic acid 
A. Efforts toward the synthesis of (+)-nodulisporic acid F were thus initiated as a proof 
of concept (Scheme 1.13).12! The eastern hemisphere (1.38), envisioned as the 
precursor for the coupling strategy, would be similar for all of the members of 
nodulisporic acid family of molecules. The major differences between the nodulisporic 
acid family members would arise from selection of the western hemisphere fragments. 
 
! 14!
 
Pleasingly, the indole formation strategy proved viable for (+)-nodulisporic acid F (1.12), 
however the aza-Peterson olefination did not procede precisedly as anticipated 
(Scheme 1.15), presumably due to the steric congestion at the C-3 quaternary center. 
Fortunately, the desired indole was still accessible employing an acid catalyzed 
dehydration of the initially derived ketoaniline 1.39. The synthesis of (+)-nodulisporic 
acid F was then completed in six steps from indole 1.40. 
Scheme 1.15. Synthesis of (+)-Nodulisporic Acid F 
 
1.4.4. PROBLEMS ASSOCIATED WITH THE D-RING FORMATION VIS-A-
VIS THE SMITH-MODIFIED MADELUNG INDOLE SYNTHETIC STRATEGY 
!
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through cleavage of the three possible bonds were considered. If the “a” bond were to 
be dissected, the D-ring could possibly be accessed through a carbonylative Heck 
process using a vinyl halide and an enamine precursor.  
 Scheme 1.16. Potential Disconnections to Synthesize the D-ring of (+)-
Nodulisporic Acid A 
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Another potential issue was discovered when attempting the Smith indole synthesis for 
the construction of (–)-nodulisporic acid A.14 Specifically, the C-24 hydroxyl group in the 
western hemisphere proved extremely labile (Scheme 1.17). When C-24 hydroxyl 
group was protected as the TES ether, exposure to strong base during the indole 
syntheses led to elimination. The elimination problem was circumvented by the use of 
the free hydroxyl, wherein the trianion of aniline 1.41 permitted the coupling reaction to 
proceed without perturbing the C-24 alcohol. After generating ketoaniline 1.42, attempts 
to remove the Boc group and close the indole ring under acidic conditions also led to 
the elimination of the C-24 hydroxyl. This result, along with the difficult D-ring synthesis, 
led the Smith group to reevaluate their coupling strategy. 
 Scheme 1.17. C-24 Hydroxyl Lability 
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1.5. A SECOND–GENERATION SMITH APPROACH: A STILLE/BUCHWALD-
HARTWIG COUPLING STRATEGY 
1.5.1. MODEL STUDIES FOR THE FORMATION OF THE CDE TRICYCLIC 
CORE OF (+)-NODULISPORIC ACID A 
 
A second-generation strategy was developed based on the lessons learned from the 
Madelung indole synthesis approach. The CDE strained tricyclic core would have to be 
approached via a different tactic (Scheme 1.18).13 Instead of dissecting through the D-
ring to form the indoline, a dissection through the E-ring to generate the indole ring with 
the pyrrolidine ring already fused to the C-ring was envisioned (Scheme 1.18). 
 Scheme 1.18. Revised Dissection of Nodulisporic Acid A 
  
A multi-step approach was developed in a model system to determine how to generate 
such a ring system (Scheme 1.19). First, stannylindoline 1.45 was found to undergo a 
palladium catalyzed Stille coupling with iodoenone 1.46 to furnish enone 1.47. 
Reduction of the enone in a 1,4 fashion with L-Selectride, followed by trapping with the 
Comins reagent15 led to vinyl triflate 1.48. The Boc group was then removed with 
trimethylsilyl iodide to reveal the unprotected indoline 1.49. Subjecting 1.49 to 
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Buchwald-Hartwig conditions completed the construction of the E-ring to produce the 
tricyclic core 1.50 in an acceptable yield (ca. 55%). 
 Scheme 1.19. CDE Tricycle Fused Indole Model Studies 
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!
 Following the model studies to determine a strategy to access the central tricyclic ring 
system, new eastern and western hemispheres were proposed (Scheme 1.20). Smith 
envisioned that (+)-nodulisporic acid A (1.1) could still be dissected at the indole ring, 
now with the possibility of devising hemispheres containing a higher degree of 
complexity.16 The requisite hemispheres for the new coupling strategy would comprise 
a western hemisphere stannylindoline (1.51) and an eastern hemisphere iodoenone 
(1.52).  
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 Scheme 1.20. Stille Coupling/Buchwald-Hartwig Cyclization Strategy 
Retrosynthetic Analysis 
 
Following completion of the synthesis of the western hemisphere 1.51 by Dr. Vlad 
Simov, a model system employing estrone was developed, to determine if the multistep 
coupling tactic would be compatible with more complex substrates (Scheme 1.21). 
Towards this end, an estrone derived eastern hemisphere model system (1.54) was 
proposed as an alternative for iodoenone 1.52.  
Scheme 1.21. Estrone Model Coupling Studies 
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Stille coupling of stannane 1.53 with iodoenone 1.54 led to enone 1.55. L-Selectride 
however was found to be ineffective for the required conjugate reduction of enone 1.55. 
Fortunately, this tranformation could be accomplished with nickel boride. Following the 
reduction, the resulting ketone was subjected to enolization with the bulky phosphazine 
base (BTPP) and trapped as vinyl triflate (1.56) with phenyl triflamide. The Boc group 
was then removed with TMSOTf to reveal the free indoline 1.57.17,18,16  
With 1.57 in hand, having the first of the two bonds constructed, the Buchwald-Hartwig 
ring closure was attempted on the estrone model system (Scheme 1.22). Unfortunately, 
none of the desired coupling product was observed. Instead, enone 1.55 was assigned 
to be the major product. 
 Scheme 1.22. Buchwald-Hartwig Indole Formation Studies 
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 This observation suggests that oxidative addition into the vinyl triflate was very slow, 
and instead the ß position was deprotonated, leading to the ejection of sulfinic acid. 
While this result was surprising, it was not without precedent. Overman reported a 
similar reaction with vinyl triflates to generate enones (Scheme 1.23). 19 
 Scheme 1.23. Overman Sulfinic Acid Ejection 
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1.6.1. INTRODUCTION OF THE BARLUENGA ONE-POT INDOLE 
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 In 2005, Barluenga reported a novel method for the one-pot synthesis of indoles from 
vinyl bromides and chloroanilines20 (Scheme 1.24). The report comprised the reactions 
of vinyl bromides, principally bromoanilines with some attention given to the 
choroanilines. Barluenga, et al. found that in the bromoaniline case, the cyclization step 
would only take place when DavePhos was employed as the ligand. Alternatively when 
choroanilines were required as the coupling partner, DavePhos was found to be 
ineffective. The ligand XPhos proved to be the best ligand for the cyclization with 
chloroaniline, suggesting that indole construction might be highly ligand specific. We 
thus envision that some optimization would be necessary if we were to attempt to apply 
the Barluenga coupling strategy to the nodulisporic acid family.  
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 Scheme 1.24. One-Pot Barluenga Indole Formation 
 
Barluenga also reported that sodium tert-butoxide was the optimum base in all cases. 
Multiple solvent systems could also be tolerated, as both dioxane and toluene were 
shown to proceed with similar yields. The reaction was also reported to tolerate 
substitution at the 1 or the 2 position of the vinyl halide, but disubstituted vinyl halides 
were not viable substrates. 
 
1.6.2. MODEL STUDIES TO ASSESS THE FEASIBLITY OF A ONE-POT 
INDOLE FORMATION STRATEGY 
!
We reasoned that the Barluenga strategy had promise, but the original report still held 
some drawbacks. If we were to apply the Buchwald-Hartwig/Heck cascade to the real 
system, 1,2-disubstituted vinyl halides would have to be permissible in the reaction. 
Initial studies to determine if the Barluenga strategy could be applied to the nodulisporic 
acid family were undertaken by Drs. Steve Gonzales and Junha Jeon.18 Model studies 
were initially conducted using 2-bromoindoline as the western hemisphere; the vinyl 
triflate derived from estrone was employed to model the eastern hemisphere of 
nodulisporic acid A.   
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 Scheme 1.25. One-Pot Indole Formation Model Studies 
 
Initially they found that under a series of screened conditions, the bromoindoline 
unfortunately coupled with itself preferentially. To lower the reactivity of the indoline 
fragment, chloroindoline was chosen as the coupling partner (Scheme 1.23). Pleasingly 
they now discovered that the coupling could be achieved with either RuPhos or XPhos 
as the ligand, employing either toluene or dioxane. These observations suggested that 
we might have some flexibility with reaction conditions as we moved to more 
complicated substrates.  
 
1.6.3. A REVISED RETROSYNTHETIC ANALYSIS 
 
To employ the one-pot Buchwald-Hartwig/Heck (Barluenga) coupling strategy, we 
envisioned chloroanine 1.62 as the western hemisphere and vinyl bromide 1.63 as the 
eastern hemisphere.  
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 Scheme 1.26. Third Generation Retrosythetic Analysis 
!
 
The chapters that follow will report our progress on the nodulisporic acid A synthetic 
program. Specifically I achieved: 
A) Revision of the required protecting group strategy that led to completion of a 
third-generation synthesis of the western hemisphere of (+)-nodulisporic acid A 
(Chapter 2); 
B) Optimization of a 2-step cuprate addition/methylation procedure to permit 
consistent access the C-3/C-12 stereogenic centers required for the successful 
synthesis the eastern hemisphere common to (+)-nodulisporic acid A and (–)-
nodulisporic acid D (Chapter 3); 
C) The total synthesis of the complete common eastern hemisphere for noduliporic 
acids A and D (Chapter 3); 
D)  Completion of the third-generation synthesis for the western hemisphere of 
nodulispoic acid D (Chapter 4) and 
E) Studies to explore the application of the one-pot Buchwald-Hartwig/Heck 
(Barluenga) union strategy. (Chapter 5) 
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CHAPTER 2. SYNTHESIS OF THE WESTERN HEMISPHERE OF 
(+)-NODULISPORIC ACID A TO EXPLORE A STILLE-
KELLY/BUCHWALD-HARTWIG UNION STRATEGY 
 
From the retrosynthetic perspective, the Stille/Bucwald-Hartwig indole 
construction tactic for the Smith second generation strategy of (+)-nodulisporic acid A 
(Scheme 2.1) was envisioned to first utilize a Stille coupling to form the carbon-carbon 
bond of the indole ring1 (Scheme 2.1). A 1,4-reduction of the enone and trapping as the 
vinyl triflate would then provide the requisite intermediates for the Buchwald-Harwig 
indole cyclization step. To achieve this strategy, stannylindoline 2.3 was envisioned as 
the western hemisphere component to implement the indole construction.  
 Scheme 2.1. The Stille/Buchwald-Hartwig Union Strategy 
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Continuing with this analysis, the requisite tetracyclic western hemisphere (2.3) would 
arise from a Nozaki-Hiyama-Kishi cyclization2 (Scheme 2.2), while the requisite benzyl 
alcohol of ketoiodide 2.5 would be installed utilizing an Enders asymmetric hydrazone 
aldol reaction.3 Installation of the indoline ring in 2.7 would then be achieved by 
employing a Buchwald-Hartwig amide union.4 Finally, a chemoselective Heck reaction 
would form the carbon-carbon bond required for oxazolidinone 2.8. 
 Scheme 2.2. Western Hemisphere Retrosynthetic Analysis 
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the key elements include a chemoselective Heck reaction (2.9 →2.12) and a 
chemoselective iodination employing Selectfluor to generate the iodonium species6 
2.14 from 2.13. Of interest, the benzoyl group was found to migrate after cyclization of 
the carbamate onto the epoxide to generate a new secondary benzoyl protected 
alcohol. Dr. Simov however found it difficult to remove the benzoyl group selectively, so 
the protecting group was changed to a SEM, reasoning that it would prove orthogonal in 
deprotections to the other protecting groups. 
 Scheme 2.3. Second-generation Western Hemisphere Synthesis for Nodulisporic 
Acid A 
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be required. The next major strategy-level step for construction of 2.3 was introduction 
of the stereocenters at C-23 and C-24 (Scheme 2.4). An Enders aldol reaction proved 
optimal to generate stereoselectively the requisite alcohol 2.16. Removal of the 
hydrazone auxiliary proved difficult and eventually required the development of new 
reaction conditions.7 The usual oxidative, acidic and basic removal conditions 
consistently led to retro-aldol products. To circumvent this, Dr. Simov discovered a new 
protocol exploiting perseleneous acid and a pH 7 buffer effective at removing the 
hydrazone, while avoiding retro-aldol products.  
 Scheme 2.4 Nodulisporic Acid A Second-generation Western Hemisphere 
Synthesis 
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at C-18 could be mesylated and selectively eliminated to furnish the desired olefin in 
2.19, by first protecting the more reactive secondary hydroxyl as the TBS ether. From 
this point, the oxazolidinone ring in (+)-2.19 was opened with lithium tertiary butoxide 
and carried forward to the desired western hemisphere 2.3.  
2.2. A REVISED PROTECTION STRATEGY 
 
 After completion of western hemisphere 2.3, Dr. Junha Jeon attempted the indole ring 
construction with the western hemisphere and a surrogate eastern hemisphere derived 
from estrone. As discussed in Chapter 1; Stille coupling and the subsequent reduction 
and triflation steps went smoothly. 
 Scheme 2.5. Trifluorosulfinic Acid Ejection 
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Unfortunately, the Buchwald-Hartwig indole ring construction did not proceed as 
planned. Instead of the indole, the material recovered proved to be the same compound 
as the enone arising from the initial Stille coupling step.  
By the time of writing this thesis, newer Buchwald biaryl phosphine ligands known to 
perform better in more difficult Buchwald-Hartwig reactions, wherein the substrates 
possess significant steric hindrance, have become available. Thus, if this strategy were 
to be revisited, a ligand screen with ligands such as XPhos or RuPhos would be 
warranted. Another observation made during the coupling studies was that the SEM 
group appeared to be unstable during the reaction. At the time, it was unclear if the 
SEM were lost or eliminated, but we reasoned that it was best to reevaluate both our 
indole construction and protecting group strategies.  
 
2.3.  SYNTHESIS OF A THIRD GENERATION WESTERN HEMISPHERE  
!
I reasoned that dissecting the molecule through the central indole remained very 
attractive, as such an approach maps well onto two fragments of similar complexity. I 
also recognized that the protecting group at the C-2’ position would be very important, 
as that would be have to be removed orthogonally from the remainder of the protecting 
groups. Our hope was that in a third generation fragment union (Scheme 2.6), we could 
employ much of the previously established routes to access a western hemisphere 2.23 
that would differ in the protecting groups at C-24 and C-2’. Also, chloroindoline 2.23 
would be emloyed, rather than stannylindoline 2.3 utilized in the second-generation 
union strategy. 
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 Scheme 2.6. Third Generation Buchwald-Hartwig/Heck Coupling Strategy 
 
 
The requisite revised western hemisphere 2.23 could also be accessed via similar 
chemistry developed for the second-generation union strategy (Scheme 2.7). 
Specifically, the B-ring of 2.23 would be constructed again via a Nozaki-Hiyama-Kishi 
cyclization.2 Generation of the C-24 alcohol of 2.25 would in turn be achieved 
stereospecifically using Enders hydrazone chemistry. The pyrrolidine ring of 2.26 would 
also be constructed as before via a Buchwald-Hartwig cyclization of an oxazolidinone 
(2.26) onto an aryl halide (2.6).  
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 Scheme 2.7. Retrosynthetic Analysis of Western Hemisphere 2.23 
 
 
2.4. THE ENDERS HYDRAZONE 2.6 
!
The requisite ketone 2.28 required for condensation with the Enders SAMP auxiliary 
was prepared via an acid catalyzed, double addition of water to commercially available 
phorone 2.27. The resultant ketone was then condensed with the Enders SAMP 
auxiliary! 3 under acidic conditions employing a Dean-Stark trap. The requisite SAMP 
auxiliary (+)-2.29 in turn was prepared following the Organic Syntheses protocol.8 
 Scheme 2.8. Enders Hydrazone Synthesis 
!
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2.5. SYNTHESIS OF ALDEHYDE 2.26 FOR THE ENDERS SAMP ALDOL  
 !
I recognized that a significant amount of the western hemisphere 2.26 (Scheme 2.9) 
would be required to complete the Enders SAMP aldol; it was therefore necessary to 
devise a cheap, reliable source for the starting bromomethyl benzoate 2.11 (Schemes 
2.7 and 2.10).  
 Scheme 2.9. Enders SAMP Aldol 
 
Previously, 3-bromobenzoic acid, an expensive starting material, was employed and the 
acid methylated in DMF with iodomethane. Utilization of the commodity chemicals, 
methyl benzoate, n-bromosuccinamide, and ferric chloride permitted my access to the 
starting bromomethylbenzoate at a fraction of the cost compared to the previous 
method. Lithium tetramethylpiperadine was then employed to ortho-lithiate benzoate 
2.11. The lithium anion generated was then transmetalated to zinc, using zinc chloride 
and the anion reacted with iodine to give iodide 2.31.  
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 Scheme 2.10. Third-Generation Western Hemisphere Synthesis 
 
Benzoate 2.31 was then reduced with DIBAL-H and resulting alcohol 2.32 converted to 
TBS ether 2.33 with tert-butyldimethylsilyl chloride employing DMAP and triethylamine. 
A chemoselective Heck reaction with ethyl acrylate was next used to generate ethyl 
cinnamate 2.12 (Scheme 2.11). The ester was reduced again with DIBAL-H and the 
free hydroxyl utilized to direct the Sharpless epoxidation.9 Previously, the 
stereochemical outcome of this epoxidation had been confirmed by X-ray analysis by 
Dr. Vlad Simov.5  
 Scheme 2.11. The Third-Generation Western Hemisphere Synthesis (cont.) 
 
 
The newly formed epoxy alcohol (–)-2.13 was next added to benzoyl isocyanate to 
generate the carbamate. Phase transfer conditions using potassium carbonate and 
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tetrabutylammonium chloride were found to effect conversion of the carbamate to the 
epoxide to generate oxazolidinone (+)-2.8 (Scheme 2.12). Under these conditions, the 
benzoyl group migrates from the oxazolidinone nitrogen to the newly generated 
secondary alcohol. Oxazoladinone (+)-2.8 was then subjected in turn to Buchwald-
Hartwig amination conditions to generate the tricyclic indoline, followed by treatment 
with methyllithium to remove the benzoate moiety to reveal the secondary hydroxyl. The 
quality of the methyllithium proved crucial to the success of the reaction. I found that 
either a new bottle or freshly prepare methyllithium was required to achieve consistent 
results. Other hydrolysis protocols proved ineffective in removing the benzoyl group 
without partial reaction at the strained oxazolidinone. Triisopropylsilyl triflate was then 
employed to generate silyl ether (+)-2.34.  
 Scheme 2.12. Third-generation Western Hemisphere Syntheis (cont.) 
 
 
Tricyclic oxazolidinone (+)-2.34 proved to be an important compound in our studies to 
develop the Buchwald-Hartwig/Heck coupling strategy. A total of 1.5 grams of (+)-2.34 
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was synthesized and delivered to Dr. Junha Jeon to generate a model western 
hemisphere. 
Selectfluor and iodine in acetonitrile were next employed to generate the highly reactive 
iodonium species.6 Unlike the Simov second-generation western hemisphere synthesis, 
wherein the SEM ether was soluble in methylene chloride, the TIPS ether proved 
completely insoluble. Other solvents were screened, but all led to partial removal of the 
TBS ether. I therefore developed new conditions wherein the iodonium species was 
generated now from silver nitrate and iodine. In 100% acetonitrile, the TBS group 
proved unstable, whereas in 100% CH2Cl2 the corresponding TIPS ether was not 
soluble. I found however that a 50:50 mixture of MeCN:CH2Cl2 was optimum for the 
iodination of the indoline (+)-2.35. Following the iodination, the TBS group was removed 
and the benzylic hydroxyl oxidized to the aldehyde [(+)-2.36] with Dess-Martin 
periodinane.10 Unfortunately, attempts at the Enders aldol reaction3 employing the 
conditions developed for the second-generation western hemisphere synthesis gave a 
mixture of diastereomers, consistently in low yields. At this point, I was given the task of 
devising and carrying out a synthesis of the eastern hemisphere for nodulisporic acids 
A and D, while Dr. Jeon carried out the remainder of the reactions to generate western 
hemisphere 2.23 (Scheme 2.6). 
 
2.6. COMPLETION OF WESTERN HEMISPHERE 2.23 BY DR. JUNHA JEON 
 
 The initial attempts to achieve the Enders aldol reaction with hydrazone (+)-2.8 and 
aldehyde (+)-2.35 proved difficult (Scheme 2.13). Fortunately, Dr. Jeon determined that 
there were a few factors that proved critical for the success of the Enders protocol. 
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First, all glassware must be cleaned in a base bath prior to the reaction. Equally 
important, if the temperature of the addition rose above –100 °C, the stereoselectivity of 
the reaction eroded dramatically. Moreover, at –78 °C the selectivity actually inverted. 
Addition of scandium triflate with the electrophile also proved important to achieve 
higher diastereoselectivity. The Enders auxiliary was then removed via the neutral 
oxidative cleavage protocol developed by Simov involving SeO2.7  
 Scheme 2.13. Completion of the Fused Ring System of the Western Hemipshere 
 Closure of the five-membered ring in (+)-2.39 was next achieved using the previously 
developed Nozaki-Hiyama-Kishi reaction to generate a diol. In the second-generation 
synthesis, addition of MsCl and DMAP proved necessary to achieve elimination of the 
tertiary alcohol to generate the olefin. In this case, the diol was protected as the TES 
ether and the tertiary alcohol fortuitously spontaneously eliminated, presumably due to 
the catalytic triflic acid, generated under the TES protection conditions to furnish the 
desired alkene (–)-2.40. To complete the western hemisphere (Scheme 2.14), the 
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oxazolidione ring of (+)-2.40 was then opened with LiOt-Bu to yield the corresponding 
Boc protected indoline possessing a primary hydroxyl group, the latter protected as the 
TES ether using TESCl and triethylamine. The Boc group was then employed to direct 
ortho-lithiation of the indoline ring; the derived aryl anion in turn was reacted with 
hexachloroethylene to furnish chloride (+)-2.41. The TES group was next removed with 
PPTS in methanol to reveal the primary hydroxyl, which was oxidized to the aldehyde 
employing the Ley protocol.11 Addition of methyl magnesium chloride then led to the 
secondary alcohol, which was again oxidized using the Ley conditions to furnish ketone 
(+)-2.42. 
 Scheme 2.14. Completion of the Western Hemisphere 
 
Wittig methylenation of the ketone next yielded the exo-methylene derivative, which 
upon removal of the Boc group with TMSOTf led to western hemisphere (+)-2.23 in a 
total of 27 steps from methyl benzoate 2.29. Of importance for future studies, the 
unprotected indoline was found to be quite unstable, and thus once the Boc group is 
removed, this advanced intermediate must be stored frozen in benzene at all times.  
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2.7. WESTERN HEMISPHERE RESULTS 
!
In summary, I began my studies on studies the nodulisporic acid research project with 
the development of the revised protecting group strategy outlined in this chapter, and 
then worked on synthesis of the western hemisphere of (+)-nodulisporic acid A for the 
Buchwald-Hartwig/Heck coupling approach. I successfully developed a new, highly 
scalable route to the starting 2-bromomethylbenzoate, and then developed a new 
iodination protocol utilizing a revised protecting group strategy. Finally, I began studies 
on the application of the Enders hydrazone aldol, wherein I constructed (+)-2.36, and 
then worked with Dr. Jeon to develop robust conditions for the required coupling based 
on the material I provided. Dr. Jeon was able to complete the western hemisphere of 
nodulisporic acid A in 27 steps in 5.0% yield using this material.  
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CHAPTER 3. SYNTHESIS OF THE COMMON EASTERN 
HEMISPHERE FOR NODULISPORIC ACIDS A AND D 
3.1.  SECOND GENERATION RETROSYNTHETIC ANALYSIS OF 
IODOENONE 3.1 
 
 From the outset of the proposed Stille/Buchwald-Hartwig union strategy to 
access the nodulisporic acids, we envisioned iodoenone 3.1 as the common eastern 
hemisphere coupling partner (Scheme 3.1). We reasoned that 3.1 could be accessed 
through a Johnson iodination1 of the corresponding enone. The enone in turn could be 
constructed via oxidation of the product of a ring closing methathesis reaction between 
the allylic hydroxyl and the terminal alkene side chains of 3.2.  
 Scheme 3.1. Eastern Hemisphere Retrosynthetic Analysis 
  
The challenging C-3 and C-12 stereocenters were originally thought to be installed via a 
Koga alkylation/methylation sequence employing unsaturated aldehyde 3.3. In the end, 
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in turn would be prepared from a ketone utilizing an enolization/triflate trapping 
sequence, followed by a Stille-formylation reaction. The requisite ketone 3.4 in turn was 
envisioned to arrive from the C-4 modified, methyl Wieland-Miescher ketone 3.5. 
3.2.   KEY OBSERVATIONS, REACTIONS AND SETBACKS ENCOUNTERED 
IN THE SECOND GENERATION EASTERN HEMISPHERE 
3.2.1. THE SHIBASAKI WIELAND-MIESCHER KETONE 
!
The first generation route to the eastern hemisphere began with the Wieland-Meischer 
ketone 3.8 and took advantage of a Kirk-Pietrow reaction2 to install the desired methyl 
group at the C-4 position (Scheme 3.2). Early on, Dr. Steve Gonzales recognized that 
Prof. Shibasaki had developed improved phenylalanine catalyzed conditions to generate 
the C-4 methyl derivative of the Wieland-Meischer ketone (3.11) on large scale with high 
enantiomeric excess.3 This improvement not only reduced the step count and improved 
the efficiency of the route, but also served to simplify purification on large scale. In 
particular, in the Kirk-Pietrow approach, the subsequent dissolved metal reduction (3.7 
to 3.8) created thiol biproducts that were difficult to separate and interfered with a 
subsequent scandium promoted formaldehyde aldol reaction to introduce the C-8 
quaternary center. 
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 Scheme 3.2. C-4-Me-Wieland-Miescher Ketone 
 
3.2.2. DEVELOPMENT OF A CUPRATE ADDITION/METHYLATION PROTCOL 
FOR THE INSTALLATION OF THE C-3/C-12 STEREOGENICENTERS 
 
The first generation route to eastern hemisphere 3.1 employed a Koga alkylation4 to 
set the stereochemistry at the C-12 position (Scheme 3.3). The magnesium enolate of 
imine 3.12 generated via a 1,4-addition was then trapped with iodomethane to furnish 
stereospecifically the C-3 quaternary center. While this route did generate one 
diastereomer, the approach unfortunately delivered the diastereomer that had the 
undesired stereochemistry at C-12. Presumably, the addition occurred without any 
influence from the chiral auxiliary. The subsequent Grignard reagent then added in the 
stereochemically anticipated axial fashion. Although the stereochemistry at C-12 was 
incorrect, the axial vinyl and 1,3-axial methyl groups in the resultant indermediate 
directed addition of the methyl iodide to the enolate to form the quaternary center from 
the equatorial position, which in turn led to the desired stereochemistry at C-3. To arrive 
at the desired stereochemistry at C-12, an awkward 6-step procedure (3.13 to 3.18)5 
was developed by Dr. Gonzales, that featured ozonolysis, epimerization and 
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reintroduction of the vinyl group to access the requisite stereogenicity of 3.18 (Scheme 
3.3). 
 Scheme 3.3. Koga Protocol to Access the C-3/C12 Stereocenters 
 
  Equally unsatisfactory, generation of the imine necessary for the Koga alkylation 
proved difficult. Normal dehydration techniques all failed to generate the requisite imine 
in reasonable yield. A protocol, wherein the amine and enal were repeatedly 
rotoevaporated at lower temperature in toluene was developed to effect imine formation, 
which proved difficult to reproduce on larger scales.  
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Dr. Gonzales subsequently developed a second generation route to eastern 
hemisphere 3.18 involving a new 2-step tactic to install the C-3/C-12 stereocenters. The 
plan took advantage of the reactivity of cuprate reagents to add preferentially in a 1,4 
fashion to unsaturated carbonyls (Scheme 3.4).  
 Scheme 3.4. Cuprate Addition/Fluoride-Mediated Methylation 
 
For this transformation, we postulate that the cuprate reagent coordinates first with the 
π-system of the unsaturated aldehyde.6 The axial methyl group alpha to the enal then 
directs alkylation of the enal to give the desired C-12 stereochemistry. The enolate is 
then trapped in situ as the trimethylsilyl enol ether. The resultant silyl enol ether is then 
activated to generate the corresponding enolate with a fluoride source (benzyl trimethyl 
ammonium fluoride), and then trapped with iodomethane in the presence of molecular 
sieves.7 The reaction sequence leads to a 4:1 mixture of diastereomers favoring the 
desired isomer. Unfortunately at that point Dr. Gonzales was unable to separate the 
mixture of diastereomers.  
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To achieve resolution the isomers, Dr. Gonzales next developed a three step procedure 
requiring adjustment of the protecting groups (Scheme 3.5). After removal of both TBS 
groups of 3.20, the primary alcohol was chemoselectively protected as benzyl ether 
3.22. The secondary hydroxyl was then protected as the TBS ether to furnish (–)-3.23. 
The revised protecting groups now permitted separation of the desired aldehyde 3.23 via 
flash chromatography, albeit after a very long reaction sequence.  
 Scheme 3.5. Separation of Diastereomers 
 
 
 
3.3.  A THIRD GENERATION EASTERN HEMISPHERE SYNTHESIS 
!
At this juncture, I reasoned that it might be possible to attempt a more convergent 
strategy employing a Buchwald-Hartwig/Heck coupling approach that would utilize 
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appended following the indole formation. Such a tactic however might not prove viable. I 
reasoned, for example, that following the Stille union of stannane 3.27 and iodoenone 
3.1, the subsequent conjugate reduction of the resultant enone 3.28 might not precede 
chemoselectively in the presence of the dienoate side chain.  
 Scheme 3.6. Comparison of Coupling Approaches 
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Barluenga indole synthesis see Chapter 1. With this strategy in mind, I then envisioned 
that the side-chain could be installed via a Horner-Wadsworth-Emmons reaction of 
aldehyde in vinyl bromide 3.30 (Scheme 3.7). The requisite vinyl bromide in turn could 
arise via enolization of ketone 3.31, followed by trapping as the vinyl triflate and 
conversion to the vinyl bromide using Buchwald’s palladium catalyzed, potassium 
bromide conditions. The fused cyclopentanone ring in turn would be derived from the 
same ring closing metathesis precursor 3.2 employed earlier. Finally diene 3.2 would be 
generated, employing a cuprate addition/fluoride mediated methylation tactic, starting 
with the C-4 analog of Wieland-Miescher ketone (3.5).  
 
 Scheme 3.7. Third Generation Eastern Hemisphere Retrosynthetic Analysis 
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3.4.  SYNTHESIS OF THE HORNER-WADSWORTH-EMMONS ALDEHYDE 
PRECURSOR 3.3 
 
Following the earlier precedent of Dr. Gonzales, I began the eastern hemisphere 
synthesis by protecting the more electrophilic ketone of the C-4 methyl Wieland-
Meischer ketone (+)-3.5 as the ketal employing acidic conditions with ethylene glycol 
(Scheme 3.8). Enone (+)-3.32 was then reduced utilizing sodium dissolved in liquid 
ammonia at –78 °C. The resulting sodium enolate was trapped in THF with trimethylsilyl 
chloride and triethylamine. Complete removal of the excess ammonia after the reduction 
was vital to the success of the trapping reaction to furnish the silyl enol ether; this could 
be accomplished by vacuum transfer of the excess ammonia after the excess sodium 
had been destroyed. Removal of the excess sodium required slow addition of isoprene 
with careful temperature control, as the reaction of sodium with isoprene is quite 
exothermic.  
 Scheme 3.8. Third Generation Eastern Hemisphere Synthesis 
 
The silyl enol ether generated in the dissolved metal reduction was subsequently 
employed without further purification, and subjected to an aqueous scandium triflate 
promoted formaldehyde aldol reaction.  
The resulting ketone (+)-3.33 was then reduced under hydroxyl directed reduction 
conditions using ammonium triacetoxyborohydride (Scheme 3.9).8 Following the 
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reduction, the derived mixture of the ketal and unprotected ketone was subjected to 
aqueous acid to furnish the corresponding keto diol, which was then bis-TBS protected 
to generate (+)-3.4. The sequence proceeded in a 69% yield for the three steps. Ketone 
(+)-3.4 was next subjected to enolization with potassium hexamethyl disilazane, followed 
by trapping of the enolate with phenyltriflamide to generate the vinyl triflate, which in turn 
was subjected to the Stille formylation conditions employing tetrakis-triphenylphosphene 
palladium and tributyltin hydride under a constant stream of carbon monoxide to furnish 
enal (+)-3.3. The formylation reaction was however found to produce consistent yields 
only when a new bottle of tributyltin hydride was employed, or when freshly generated 
tributyltin hydride used, the latter generated as described by Hayashi9. 
 Scheme 3.9. Third Generation Eastern Hemisphere Synthesis (cont.) 
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CuBr•PPh3, CuBr•COD, or higher order cuprates generated from (thio)Cu(CN)Li10 led to 
mixtures of 1,2-addition and 1,4-addition products. In order to obtain reproducible 
results, the copper(I) bromide employed in the reaction must be generated by reduction 
of copper(II) bromide according to the procedure by Townsend.11 The copper(I) bromide 
must then be recrystallized from dimethyl sulfide to generate the CuBr•SMe2 complex. 
After recrystallization, the white solid must be carefully air dried in a desiccator, not 
under high-vac. If the CuBr•SMe2 is stored for more that 3 months in the desiccator, it 
must again be recrystallized from dimethyl sulfide to ensure high quality copper(I). The 
Grignard reagent quality is also important for the success of the conjugate addition 
reaction. Vinyl magnesium bromide should be generated prior to use from vinyl bromide 
and magnesium. The concentration of the Grignard reagent should be no higher than 0.7 
M, given that the Grignard reagent starts to precipitate from solution at higher 
concentrations. If the Grignard reagent does happen to precipitate, the solids should not 
be used in the generation of the cuprate. Equally important, after working up the 
reaction, the remaining HMPA and dimethyl sulfide make removal of water with 
dehydrating agent (cf. MgSO4, Na2SO4, molecular sieves) very difficult. Also important, 
given the TMS enol ether generated in the reaction is sensitive to column 
chromatography; the mixture, without purification, should be used directly in the 
methylation step. If all water is not removed, the enolate generated by activation of the 
TMS enol ether with MeLi12, BTAF7, or KOEt13 will be immediately quenched. 
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 Scheme 3.10. Failed Hydrolysis Recovery 
 
On several occations, attempts were made to recover the aldehyde product that had 
arisen upon hydrolysis of 3.19 (Scheme 3.10). Attempts at reenolization of the 
recovered hindered aldehyde failed.  Also of note, use of bases such as NaH, KH, Et3N 
and t-BuLi with either iodomethane or TMSCl as electrophiles consistently returned only 
the starting aldehyde 3.34. 
 Another major issue in the larger scale cuprate addition was the difficulty of removing all 
traces of water from the reaction mixture. In order to remove all water, it is imperative 
that the mixture is heated to 100 °C under high vacuum. Dr. Gonzales had also shown 
that utilizing benzyltrimethyl ammonium fluoride (BTAF) to activate the silyl enol ether 
effectively generated the desired aldehyde (–)-3.23. Unfortunately scales larger than 100 
mg, the difficulty with complete removal of water from BTAF led to significant amounts of 
the hydrolyzed enol ether.  
 To circumvent these issues, I discovered that the lithium enolate could be generated 
utilizing the Stork protocol, that is by addition of MeLi to the silyl enol ether (Scheme 
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chromatography proved ineffective at separating the diastereomers generated in this 
reaction, use of MPLC permitted isolation of the desired diastereomer (–)-3.23. 
Scheme 3.11. Vinyl Cuprate Addition/Methylation 
 
   Having success with the cuprate addition/methylation step, the vinyl Grignard reagent 
was then added to aldehyde (–)-3.23 (Scheme 3.12). The resultant diene was then 
subjected to ring closing methathesis employing the second generation Grubbs catalyst 
to generate the tricyclic allylic alcohol, which pleasingly was isolated as a single 
diastereomer. The stereochemistry of the hydroxyl group however was not determined 
given that the next required step was oxidation to the enone employing the Dess-Martin 
conditions.14 The resultant enone was then reduced to (–)-3.31 with Pd/C and hydrogen.  
 Scheme 3.12. Synthesis of Vinyl Bromide (–)-3.21  
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the Buchwald-Hartwig/Heck(Barluenga) reaction cascade. Dr. Jeon, however, had 
shown that the triflate was not sufficiently robust with a similar substrate to withstand the 
Horner-Wadsworth-Emmons (HWE) conditions envisioned to install the requisite side-
chain. In particular he found that the triflate was removed under HWE conditions to 
reveal the ketone. Interestingly, the aldehyde proved sufficiently sterically encumbered 
such that the reactivity was similar to that of the cyclopentanone carbonyl, and thus 
mixtures of olefin products derived from each of the carbonyl groups were observed. !
To overcome this issue, the triflate generated from ketone (–)-3.31 was converted to the 
vinyl bromide using Buchwald’s palladium catalyzed bromination conditions15 (Scheme 
3.12). Buchwald reported that t-BuBrettPhos was the best ligand for bromide generation, 
but t-BuXPhos was also effective. Given the expense of the former we chose to employ 
t-BuXPhos to provide a mild, reproducible route to the highly versatile intermediate vinyl 
bromide (–)-3.35. The TBS groups were then removed from (–)-3.35 with TBAF at 50 °C, 
to furnish the diol; the primary alcohol was next oxidized chemoselectively to the 
aldehyde with TEMPO and acetoxyiodobenzene (Scheme 3.13), and the secondary 
hydroxyl was then protected as the TES ether. Importantly, the size of the protecting 
group on the secondary hydroxyl was eventually found to be very important vis-a-vis the 
Horner-Wadsworth-Emmons reactivity of the aldehyde (vide infra). Anything larger than 
a TES group blocked access to the aldehyde with most nucleophiles. 
 Scheme 3.13. Horner-Wadsworth-Emmons Aldehyde Precursor 
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3.6. SYNTHESIS OF THE HORNER-WADSWORTH-EMMONS 
PHOSPHONATE  
 
As outlined in Section 3.3 the third generation eastern hemisphere 3.29 was envisioned 
to incorporate the fully elaborated side chain dienoate. Towards this end, Dr. Gonzales 
had developed an approach to the side-chain Horner-Wadsworth-Emmons phosphonate  
that employed radical bromination of methyl tiglate (Scheme 3.16). This approach 
unfortunately resulted in an inseparable mixture of brominated compounds. Although the 
mixture could be subjected to the Arbuzov16 reaction, the resultant mixture of 
phosphonate isomers 3.38 and 3.40 could not be readily separated, and thus this 
approach to the HWE phosphonate was simply not practical. 
 Scheme 3.14. Previous Synthesis of the Phosphonate Side Chain 
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allylic alcohol 3.43 with borane•THF complex, and in turn converted to bromide 3.44 
under the Appel conditions.17  
 
 Scheme 3.15. Side Chain Phosphonate Synthesis 
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only way they were able to install the desired olefin was via a two step procedure. First, 
they discovered that the Ohira-Bestmann reagent19 was sufficiently small to react at the 
aldehyde center to generate alkyne 3.46. Next, a hydrozirconation/iodination sequence 
proved effective for elaboration of the subsequent alkyne to vinyl iodide 3.47.  
 Scheme 3.16. Snapper Aldehyde Elaboration Strategy 
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hexamethyldisilazane, followed by capture of the enolate with phenyltriflamide furnished 
vinyl trifilate 3.48. The triflate was then converted to vinyl bromide 3.49 and 
subsequently treated with TBAF to provide diol 3.50. The primary alcohol of diol 3.50 
was then oxidized chemoselectively to the aldehyde 3.51 utilizing TEMPO and the 
secondary alcohol protected as TES ether 3.52. 
 Scheme 3.17. Eastern Hemisphere Model 
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Evans and Miller,20 n-BuLi proved to be an excellent base for the Horner-Wadsworth-
Emmons coupling. Slow deprotonation with n-BuLi at 0 °C led to a yellow solution that 
could be warmed to room temperature with very little precipitate formation. Generation of 
the phosphonate anion utilizing this protocol furnished dienoate 3.53 in an 86% yield. 
This observation suggests that the counter-ion is critical to generation of stable 
phosphonate anions. 
 Scheme 3.18. Eastern Hemisphere Model 
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 Scheme 3.19. Eastern Hemisphere Model Deprotection 
 
 
To generate the fully elaborated eastern hemisphere (–)-3.26 required for the Buchwald-
Hartwig/Heck coupling strategy, (–)-3.30 was subjected to the Horner-Wadsworth-
Emmons conditions, as in the case of the model system 3.52 (Scheme 3.18). 
Pleasingly, the olefination proceeded in a 64% yield to provide the eastern hemisphere 
(–)-3.26 required for union to a western hemisphere (Scheme 3.20).  
 Scheme 3.20. Completion of the Third Generation Hemisphere 
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3.8. OVERVIEW OF THE EASTERN HEMISPHERE RESULTS 
 
The synthesis of eastern hemisphere 3.26 required for the Buchwald-Hartwig/Heck 
coupling cascade was achieved in 20 steps, in a 9.3% overall yield. The successful 
synthesis of (–)-3.26 required the development of more robust conditions for the two 
step cuprate/methylation sequence, which in turn led to the generation of sufficient 
material for further investigation. A vinyl triflate to vinyl bromide conversion was then 
successfully developed to ensure, that under Horner-Wadsworth-Emmons conditions, 
the requisite addition of the dienoate side chain could be achieved. Thus, for the first 
time in the Smith group synthetic studies of the nodulisporic acid family of alkaloids, a 
strategy was in hand to access an advanced fully elaborated eastern hemisphere [i.e., (–
)-3.26].  
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CHAPTER 4.  A NEW SYNTHESIS OF THE WESTERN 
HEMISPHERE OF (–)-NODULISPORIC ACID D 
4.1 RETROSYNTHETIC ANALYSIS OF WESTERN HEMISPHERE OF (–)-
NODULISPORIC ACID D 
!!!!!!!!!!!An overview of our second generation synthetic analysis for (–)-nodulisporic Acid 
D is illustrated in Scheme 4.1A, and was based on earlier work of the Smith group. In 
fact, Dr. Akin Davulcu had completed the core heptacyclic ring system 4.4 utilizing the 
modified Madelung indole synthesis developed in the Smith group for a total synthesis 
of (–)-nodulisporic acid D (Scheme 4.1B).1  
 Scheme 4.1 Retrosynthetic Analysis of (–)-Nodulisporic Acid D 
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However, attempts to attach the side chain to the core ring system failed. Looking to 
employ the newer Buchwald-Hartwig/Heck coupling strategy, I envisioned utilizing 
chemistry similar to what was developed by Dr. Davulcu. The western hemisphere 4.2 
required for the Buchwald-Hartwig/Heck cyclization strategy would only differ by 
changing the aryl methyl substitution to an aryl chloride for the revised coupling partner 
4.2. I reasoned that by applying the previously developed chemistry, we could access 
the needed western hemisphere quickly and efficiently. The final ring closure to form the 
5-membered ring in 4.2 with desired olefin geometry, would be accomplished via use of 
a Stille-Kelly reaction (Scheme 4.2).2 The only stereocenter required for the western 
hemisphere would again be set using an Enders alkylation reaction, while the required 
benzyl bromide 4.9 would be derived from carboxylic acid 4.12 through a series of 
reduction and halogenation steps. 
 Scheme 4.2 Retrosynthetic Analysis of the Western Hemipshere of (–)-
Nodulisporic Acid D 
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4.2  SYNTHESIS OF WESTERN HEMISPHERE OF (–)-NODULISPORIC ACID 
D 
The synthetic strategy carried out for the western hemisphere for nodulisporic acid D 
was initially done in collaboration with Matthew Spafford. The route begins with the 
reduction of chloronitrobenzoic acid 4.12 with the borane•THF complex to yield alchohol 
4.13 (Scheme 4.3). The aryl nitro group of alcohol 4.13 was then reduced with 
hydrochloric acid and iron, and the resulting amino alcohol was converted to TBS ether 
4.14 using standard TBSCl and imidazole protocol.  
 Scheme 4.3 Synthesis of 2-Chloro-4-iodo-aniline 
 
Following similar conditions from Dr. Davulcu’s work, aniline 4.14 was chemoselectively 
iodinated with BTMA(benzyl trimethylammonium)•ICl2.3 It was also found that the 
AgNO3/I2 conditions used for the western hemisphere of nodulisporic acid A were 
equally effective for the chemoselective iodination to aniline 4.14. I next reasoned that a 
free aniline would not be compatible with the Enders alkylation proposed to set the 
homobenzylic stereochemistry. A phthalimide protecting group was thus chosen to 
remove all acidic protons from the molecule that could be problematic under the highly 
basic conditions. Aniline 4.15 was thus converted to phthalimide 4.16 using phthalic 
anhydride and triethylamine under Dean-Stark conditions. The TBS ether was then 
removed to reveal the benzylic hydroxyl under acidic aqueous conditions to furnish 
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alcohol 4.17. Next, benzyl bromide 4.9, necessary for the Enders alkylation, was 
generated by applying the Appel conditions4 to alcohol 4.17.  
 Scheme 4.4 Synthesis of the Enders Alkylation Benzyl Bromide 
 
I found that the Enders alkylation5 to be much more difficult to achieve than originally 
anticipated (Scheme 4.5). In earlier reported examples of either the Enders aldol 
reaction or alkylations, the base employed for deprotonation of the hydrazone was most 
often LDA. Unfortunately, I found that LDA was ineffective for the alkylation and that tert-
butyl lithium was required as the base to achieve deprotonation of the hydrazone. In 
order to achieve consistent yields, all glassware must be base-bathed prior to each 
reaction. Maintaining a temperature of  –100 °C (or below) was also crucial, not only for 
achieving good diastereoselectivities, but also for the requisite desired reactivity. It 
appears that addition of the benzyl bromide electrophile at temperatures above –100 °C 
leads to products where the nucleophile reacts preferentially with the phthalimide. 
Moreover, addition of the benzyl bromide at –78 °C led to only decomposition of the 
starting materials.  
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 Scheme 4.5 Enders Alkylation 
 
Following the Enders alkylation to furnish hydrazone (+)-4.7, the hydrazone was 
removed utilizing neutral oxidative conditions developed by Dr. Simov6. The conditions 
required modification from the original protocol to account for solubility issues. Addition 
of THF was required as a cosolvent, given that the pH 7 buffer/MeOH solvent system 
proved to be too polar. Ozonolysis could also be used to access the ketone, but the 
yields tended to be inconsistent. Ketone (–)-4.18 was then subjected to enolization with 
potassium hexamethyl disilazane and trapped as the vinyl triflate employing 
phenyltriflamide to furnish (–)-4.19. In this case, phenyl triflamide was added to the 
reaction mixture prior to addition of the base to furnish the most consistent results.  
Triflate (–)-4.19 was then subjected to the Stille-Kelly conditions2 to close the 5-
membered ring in (–)-4.20 (Scheme 4.6). Vital for the success of the reaction was the 
use of only new ampules of hexamethyl ditin. Treating phthalamide (–)-4.20 with 
hydrazine in ethanol then revealed the western hemisphere 4.2. Pleasingly the synthesis 
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of the western hemisphere chloroaniline (–)-4.2, required for the one-pot Buchwald-
Hartwig/Heck reaction, was achieved in 11 steps with an overall yield of 4.0%. 
 Scheme 4.6 Synthesis of the Western Hemisphere of Nodulisporic Acid D 
 
In summary, a new 11 step synthesis of the nodulisporic acid D western hemisphere has 
been achieved.  
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CHAPTER 5.  THE BUCHWALD-HARTWIG/HECK COUPLING 
STRATEGY 
5.1.  MODEL STUDIES TO ASSESS THE FEASIBLITY OF A ONE-POT 
INDOLE CONSTRUCTION STRATEGY 
!
As outlined in Chapter 1, we reasoned that the Barluenga indole synthesis strategy held 
great promise for nodulisporic acid A and D synthesis, but the original report had 
significant drawbacks. If, for example, we were to apply the Buchwald-Hartwig/Heck 
cascade to the real system, 1,2-disubstituted vinyl halides would have to be permissible 
in the reaction. Studies to determine if the related Barluenga strategy could be applied to 
the nodulisporic acid family were initially undertaken by Drs. Steve Gonzales and Junha 
Jeon.1,1a Model studies were initially conducted using 2-bromoindoline 5.1 as a model for 
the western hemisphere and the vinyl triflate derived from estrone 5.2 to model the 
eastern hemisphere of nodulisporic acid A.   
 Scheme 5.1. Buchwald-Hartwig/Heck Model Studies 
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Gonzalez and Jeon found that under all conditions screened, the bromoindoline coupled 
preferentially with itself. To lower the reactivity of the indoline fragment, chloroindoline 
5.4 was chosen as the coupling partner. Pleasingly, the coupling could now be achieved 
with either RuPhos or XPhos as the ligand with toluene or dioxane employed as the 
solvent. These results suggested that we might have some flexibility with reaction 
conditions as we moved to more complicated substrates.  
To model nodulisporic acid A more closely, Jeon chose an intermediate along the route 
to the western hemisphere, namely chloroindoline 5.7 as the western hemisphere 
surrogate, and continued to use the eastern hemisphere model derived from estrone 5.5 
(Scheme 5.2). With the added complexity, the conditions used on the previous model 
system, namely Pd2dba3/XPhos as the Pd catalyst, failed. In this case the palladium 
source proved critical to the success of the reaction.  
 Scheme 5.2. Truncated Western Hemisphere/Estrone Model Coupling Studies 
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The Pd2dba3/XPhos conditions were simply not efficient at generating active Pd0. To 
overcome the reactivity issue, Buchwald’s palladacycle pre-catalyst2 was employed as 
the palladium source to generate highly active mono-ligated Pd(0), which did in fact lead 
to coupled product 5.5 in a 40% yield. Higher temperatures and palladium loadings were 
necessary to obtain the best yields in this reaction. With coupling conditions developed 
to construct the highly strained, tricyclic indole core of nodulisporic acid A, I undertook to 
advance the model studies further to determine if the previously problematic C-24 
hydroxyl group of the western hemisphere of nodulisporic acid A would be compatible 
under these reaction conditions. Using the western hemisphere (5.9) developed by Dr. 
Jeon, that I also prepared, and the eastern hemisphere model derived from estrone 
(5.5), the coupling conditions developed on the truncated system were applied to the 
more elaborate system (Scheme 5.3). 
 Scheme 5.3. Nodulisporic Acid A Western Hemisphere/Estrone Model Coupling  
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Pleasingly, I found that the coupling proved successful at generating the indole without 
any observation of elimination of the C-24 hydroxyl. Importantly, the synthesis of 5.10 
represents the first time that the entire A,B,C,D,E fused, pentacyclic ring system 
for nodulisporic acid A had been successfully constructed. 
 Looking forward, I knew that the end-game strategy would rely heavily on the correct 
choice of protecting groups, and in particular that the successful completion of 
nodulisporic acid A would require chemoselective removal of the TES ethers in the 
presence of the TIPS ether. The advanced estrone analogue of nodulisporic acid A 5.10 
was therefore used as a model system to determine which conditions would permit 
access to the C-24 hydroxyl, while retaining the triisopropyl silyl ether. Initially, I thought 
to take advantage of chemistry reported by Merck, where the C-24 hydroxyl had also 
been protected as a triethyl silyl ether. Merck had been able to use PPTS in ethanol to 
remove the TES ether.3 In our hands however, once the hydroxyl group was revealed, 
any exposure to acid quickly led to elimination of the hydroxyl group to generate the 
diene. In fact, if the free alcohol was dissolved in deuterated chloroform for NMR 
purposes, the clear solution would quickly turn yellow as the hydroxyl group eliminated 
to form the more conjugated system. Fortunately, I found that basic conditions could be 
employed to remove the TES ether. Specifically, slow addition of TBAF at 0 °C 
effectively generated alcohol 5.11 without affecting the TIPS ether.  
5.2. POSSIBLE MECHANISTIC PATHWAYS: A KEY CONSIDERATION FOR 
THE FUTURE OF THE SMITH NODULISPORIC ACID SYNTHETIC 
PROGRAM 
!
Computational studies involving palladium catalyzed enamine cyclizations to construct 
indoles were previously conducted by the Kurth group (Scheme 5.4).4 In their work, the 
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indole cyclization mechanism was postulated to procede via a typical Heck 1,2-insertion 
pathway. For example, in a typical Heck reaction, a direct 1,2-migratory insertion from 
enamine 5.13 to palladated indoline 5.15 would be expected. 
 Scheme 5.4. Kurth Computational Studies 
!
 Interestingly, their computational studies were unable to find a transition-state structure 
corresponding to such an insertion. Instead, they discovered that a step-wise 
mechanism most likely pertained, where an anilinium palladacycle 5.14 was favored as 
the first step. Indole 5.17 could then be accessed through one of two pathways from 
palladacycle 5.14. First, a Heck-type process could occur, wherein the palladium would 
undergo a stepwise 1,2-insertion to generate indoline 5.15. Beta-hydride elimination 
from the indoline would then provide indole 5.17. Alternatively, deprotonation of the 
acidic alpha-proton of anilinium intermediate 5.14 would lead to enamine palladacycle 
5.16. This in turn could undergo reductive elimination to provide indole 5.17. Although, 
both pathways are permissible, the Kurth group postulated that the nucleophilic 
attack/deprotonation pathway was in fact preferred.  
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 We believe these observations provide some insight into our Barluenga indole 
construction strategy (Scheme 5.5). In the case of nodulisporic acid D, the reaction 
mechanism is most similar to that proposed in the Kurth computational studies. A step-
wise Heck-type mechanism for the indole formation is likely not the preferred pathway. 
 Scheme 5.5. Nodulisporic Acid D Mechanistic Possibilities 
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The beta-hydride of indoline intermediate 5.22 required for elimination to generate indole 
5.24 resides on the inaccessible, opposite face in relation to palladium. Instead, the 
nucleophilic attack/deprotonation pathway is reasoned to lead first to 5.23. In this case 
intermediate iminium 5.23 would then undergo deprotonation to access an enamine 
intermediate, that in turn would eliminate reductively to furnish indole 5.24. 
!
!
5.3. TOWARDS THE TOTAL SYNTHESIS OF NODULISPORIC ACID D  
!
At this stage, we had in hand the requisite eastern and western hemispheres (5.18 and 
5.25) containing all of the required carbons for a total synthesis of nodulisporic acid D 
(Scheme 5.5). There was some concern however that the dienoate portion of the 
eastern hemisphere may not withstand the harsh union reaction conditions. Accessing 
the full carbon skeleton after the coupling step would of course greatly simplify the end-
game strategy. For example, indole 5.26, if available, would require only a silyl group 
removal and saponification to access nodulisporic acid D. Unfortunately, all attempts at 
coupling chloroaniline 5.18 and vinyl bromide 5.25 to generate indole 5.26 proved 
unsuccessful. 1H  NMR spectral analysis suggests the vinyl bromide was reduced to the 
alkene under the reaction conditions. It was however unclear what the fate of the 
chloroaniline fragment was after the reaction.  
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 Scheme 5.6. (–)-Nodulisporic Acid D Coupling 
 
This unfortunate result forced us to reevaluate our overall retrosynthesis. We thought we 
might have more success if we took a more conservative approach using less 
functionalized fragments (Scheme 5.7). A truncated eastern hemisphere (5.18) could be 
used without the sidechain dienoate. Towards this end, a Horner-Wadsworth-Emmonds 
reaction would then have to be carried out on the full ring system to add the side chain 
necessary to complete nodulisporic acid D. Unfortunately, again all attempts to couple 
chloroindoline 5.18 with vinyl bromide 5.22, proved unrewarding. An inseparable mixture 
of compounds was obtained that did however show promise by UV analysis. The mixture 
appeared to have UV absorbances that would be consistent with an indole. But, we were 
unable either to observe a MS parent ion consistent with the desired compound and or 
obtain a clean NMR of what appeared to be the coupled product.  The only mass 
present in the MS was the desired mass plus two mass units. As the mixture proved 
inseparable by a combination of flash chromatography, preparative TLC, MPLC or 
HPLC, I attempted to remove the tert-butyldimethyl silyl groups to permit purification. 
Unfortunately, the diol also proved to be an inseparable mixture, again displaying a 
mass that was 2 units higher then the desired mass. This observation suggests that the 
indole formation was actually taking place as intended. However, without C-24 hydroxyl 
possessing a bulky protecting group, the western hemisphere alkene may be more 
accessible to other chemistry under the somewhat harsh coupling conditions. At this 
point, I had expended nearly all of the advanced intermediates.  
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 Scheme 5.7. Truncated (–)-Nodulisporic Acid D Coupling 
 
 
5.4. FUTURE PLANS TO OPTIMIZE THE COUPLING REACTION 
!
The results that I have obtained from the model studies and reactions reported in this 
thesis on the fully elaborated systems have provide some insight as to how to move 
forward and to improve the coupling strategy. It appears that the Buchwald-Hartwig 
reaction is highly sensitive to the steric differences between the estrone derive model 
eastern hemisphere and the real eastern hemisphere.  
 Scheme 5.8. Future Plans to Optimize the Coupling Reaction 
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Also, one of the major drawbacks of the current optimized conditions employing in the 
estrone model eastern hemisphere, is that two equivalents of the eastern hemisphere 
are required and that 40 mol % palladium is necessary to drive the reaction to 
completion. Optimized reaction conditions for the model eastern hemisphere 
unfortunately do not appear to translate well to the real nodulisporic acid D system. In 
order to determine the optimal conditions for the real system, the Merck screening facility 
at the University of Pennsylvania should be employed in the future. Chloroaniline 5.18 
could be used as the western hemisphere in such screens. Reactions of vinyl bromides 
such as 5.22 possessing bis-TBS protected hydroxyls however may be difficult to follow 
by HPLC or LC/MS as no chromophore is present: moreover this system appears not to 
undergo ready ionization during LC/MS analyses. It would thus appear advisable to 
exchange the TBS groups with tert-butyl diphenyl silyl groups such as in 5.25. Hopefully, 
this minor change would not affect the reactivity of the various advanced intermediates 
in any significant manner, but would incorporate a chromophore that would make the 
analysis of the catalyst screen more facile. This same approach could also be taken to 
optimize conditions for nodulisporic acid A. Moreover, the Merck resource would provide 
access to a wider variety of catalysts, ligands, and conditions, while using less precious 
late-stage material.  
5.5. REFERNCES FOR CHAPTER 5 
!
1. (a) Gonzales, S. Synthetic Studies Of (+)-Nodulisporic Acid A: Development Of 
An Efficient Route To Eastern Hemisphere Sub-Targets. University of Pennsylvanita, 
2011; (b) Jeon, J., Unpublished Results. University of Pennsylvania: 2012. 
2. Biscoe, M. R.; Fors, B. P.; Buchwald, S. L., A New Class of Easily Activated 
Palladium Precatalysts for Facile C−N Cross-Coupling Reactions and the Low 
! 86!
Temperature Oxidative Addition of Aryl Chlorides. J.Am. Chem. Soc. 2008, 130 (21), 
6686-6687. 
3. Chakravarty, P. K.; Shih, T. L.; Colletti, S. L.; Ayer, M. B.; Snedden, C.; Kuo, H.; 
Tyagarajan, S.; Gregory, L.; Zakson-Aiken, M.; Shoop, W. L.; Schmatz, D. M.; Wyvratt, 
M.; Fisher, M. H.; Meinke, P. T., Nodulisporic acid side-Chain modifications: access to 
the 2'', 3'', 4'', and 6'' registers. Bioorg. Med. Chem. Lett. 2003, 13 (1), 147-150. 
4. Knapp, J. M.; Zhu, J. S.; Tantillo, D. J.; Kurth, M. J., Multicomponent Assembly of 
Highly Substituted Indoles by Dual Palladium-Catalyzed Coupling Reactions. Ang. 
Chem. Int. Ed. 2012, 51 (42), 10588-10591. 
!
!
!
! 87!
 
6.1 MATERIALS AND METHODS 
All solvents used were reagent grade.  Diethyl ether (Et2O), tetrahydrofuran (THF), 
methylene chloride, and toluene were obtained from a PurSolv™ PS-400. All reagents 
were purchased from Aldrich or Acros and used as received. Reactions were 
magnetically stirred in oven-dried glassware under an argon atmosphere and monitored 
by thin layer chromatography (TLC) with 0.25 mm E. Merck pre-coated silica gel plates.  
All starting materials were azeotroped with benzene (3x) and dried under vacuum prior 
to use.  Flash chromatography was performed with silica gel 60 (particle size 0.040 – 
0.062 mm) supplied by Silicycle and Sorbent Technologies.  MPLC refers to medium 
pressure liquid chromatography (25-200 psi) using hand-packed columns of Silasorb 
silica gel (18-32 µm, 60 Å pore size), a Waters HPLC pump, a Waters R401 differential 
refractive index detector, and a Gilson 116 UV detector.  Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.  
Infrared spectra were recorded on a Jasco Model FT/IR-480 Plus spectrometer.  Proton 
and carbon NMR spectra were recorded on a Bruker AMX-500 and Bruker Avance III 
500 MHz spectrometer.  Chemical shifts are reported relative to either chloroform (δ 
 7.27) or benzene (δ 7.16) for 1H NMR and either chloroform (δ 77.16) or benzene (δ 
128.4) for 13C NMR.  Optical rotations were measured on a Perkin-Elmer model 241 
polarimeter or a Jasco polarimeter.  High resolution mass spectra were measured at the 
University of Pennsylvania Mass Spectrometry Service Center. 
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Bromomethylbenzoate 2.11:  
Commercially available methyl benzoate (100 mL, 771 mmol) in a sealed tube was 
dissolved in MeCN (100 mL, 7.71 M).  NBS (106.9 g, 600 mmol, 0.778 equiv) and FeCl3 
(48.7 g, 300 mmol, 0.389 equiv) were added to the solution and the sealed tube was 
closed.  The reaction mixture was warmed to 110 °C and stirred for 48 h.  The reaction 
mixture was quenched with saturated aqueous Na2S2O3 and extracted with Et2O.  The 
combined organic layer was washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo to give the crude product. The starting material, methyl benzoate 
was first distilled under a reduced pressure (bp 58 °C / ca. 10 torr) as a clear colorless 
oil (37 g, 35 %) and the product 2.11 was distilled under a reduced pressure (bp 120 °C / 
ca. 10 torr) as a clear colorless oil (106 g, 64 %). 1H NMR (500 MHz, CDCl3): δ 8.19 
(ddd, J = 2.1, 1.6, 0.5 Hz, 1H), 7.98 (ddd, J = 7.8, 1.6, 1.1 Hz, 1H), 7.69 (ddd, J = 8.0, 
2.0, 1.1 Hz, 1H), 7.33 (ddd, J = 7.9, 7.9, 0.5 Hz, 1H), and 3.94 (s, 3H);  13C NMR (125 
MHz, CDCl3): δ 166.0, 136.1, 132.9, 132.3, 130.2, 128.4, 122.7, and 52.6; HRMS (ESI): 
Calcd for (M+H)+: 213.9629; Found m/z: 213.9677. 
 
 
 
 
 
 
MeO2C Br
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Iodide S2.1: 
Preparation of Tetramethylpiperidine (TMP):   
i) Hydrazine hydrate (59.6 mL, 64% purity, 1.227 mol) was added over to a 
triacetoneamine (117.5 g, 0.757 mol).  The reaction mixture was warmed to 60 °C and 
stirred for 3.5 h.  
 ii) KOH (2.76 g, 0.0492 mol), diethylene glycol (14.6 mL), and paraffin oil (3.5 mL) were  
added to a 3-neck flask, which was assembled with 25 cm vigreux column and a 
distillation apparatus.  The mixture was heated to ca. 210°C (±10 °C) and the hydrazone 
mixture was transferred via a cannula.  Water was first distilled out and later TMP was 
distilled as a clear colorless oil (91.7 g, 85.8 %). 
ii) TMP (36 mL, 212.8 mmol) was dissolved in THF (266 mL, 0.5 M) and n-BuLi (89.4 
mL, 2.38 M, 212.8 mmol) was added to the solution at –20 °C.  The reaction mixture was 
stirred for 30 min.  The mixture was cooled to –78 °C and ester 2.11 (28.6 g, 133 mmol) 
in THF (60 mL) was added to the mixture via a syringe pump over 1.5 h, where the 
reaction mixture was stirred for 0.5 h. ZnCl2 [(266 mL, 1.0 M in Et2O), prepared through 
drying in vacuo at 185 °C for 22 h and then dissolved in Et2O)] was added to the mixture 
via a syringe pump over 0.5 h and was stirred for 0.5 h.  I2 (54 g, 212.8 mmol) in THF (80 
mL) was added over 1 h.  The reaction mixture was quenched with saturated aqueous 
NH4Cl and extracted with Et2O.  The combined organics were washed with brine, dried 
over MgSO4, filtered and concentrated in vacuo.  The resulting crude material was 
purified via flash chromatography (10:1 = hex:EtOAc) or MPLC (7.5:1 = hex:EtOAc) to 
afford methyl 3-bromo-2-iodobenzoate S2.1 (43 g, 83%) as an inseparable mixture (7:1 
= product:starting material), which was taken forward without further purification. 1H 
Br
I
MeO
O
! 90!
NMR (500 MHz, CDCl3): δ 7.73 (dd, J = 8.0, 1.5 Hz, 1H), 7.45 (dd, J = 7.6, 1.6 Hz, 1H), 
7.24 (t, J = 7.8 Hz, 1H), and 3.94 (s, 1H);  13C NMR (125 MHz, CDCl3): δ 167.9, 140.9, 
134.8, 132.7, 129.3, 128.0, 101.0, 53.0.  HRMS (ESI): Calcd for (M+H)+: 339.8596. 
Found m/z: 339.8615 
 
 
Alcohol S.2: 
The ester S2.1 (38.5 g, 113 mmol) was dissolved in THF (226 mL) and the solution was 
cooled to –78 °C.  DIBAL-H (2.82 mL, 1.0 M in hexanes) was added to the solution over 
1.5. The –78 °C bath was then replaced with a –20 °C ice/salt bath.  After being stirred 
for 30 min at –20 °C, the reaction was first quenched with EtOAc and then half-saturated 
aqueous Rochelle salt.  After being stirred for 2 h, the mixture was extracted with Et2O.  
The combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo.  The crude solid material was triturated with hexanes. The 
resulting liquid was concentrated in vacuo and was purified by flash chromatography 
(8:1 to 4:1 = hex:EtOAc) affording the alcohol S2.2 (35 g, 99%) as a clear colorless oil. 
1H NMR (500 MHz, CDCl3): δ 7.58 (dddd, J = 7.9, 1.6, 0.6, 0.6 Hz, 1H), 7.38 (dddd, J = 
7.6, 1.6, 0.8, 0.8 Hz, 1H), 7.24 (t, J = 7.8 Hz, 1H), 4.69 (d, J = 5.6 Hz, 2H), 2.34 (t, J = 
5.9 Hz, 1H);  13C NMR (125 MHz, CDCl3): δ 146.4, 131.9, 131.3, 129.7, 126.4, 104.3, 
71.2;   HRMS (CI+): Calcd for (M–OH)+: 294.8619. Found m/z: 294.8619. IR (thin film, 
neat): 3248 (br, m), 2917 (w), 1400 (m), 1051 (s) cm–1. 
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TBS ether 2.9: 
The alcohol S2.2 (21.42 g, 68.45 mol), DMAP (418 mg, 3.423 mmol), and Et3N (19.06 
mL, 136.9 mmol) were dissolved in CH2Cl2 (136.9 mL), and tert-Butyldimethylsilyl 
chloride (11.86 mL, 78.72 mmol) was added to the solution.  After being stirred for 2 h, 
the reaction mixture was quenched with saturated aqueous NaHCO3 and extracted with 
CH2Cl2.  The combined organics were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo.  The residue was purified by flash chromatography (15:1 = 
hex:EtOAc) amc afforded the silyl ether 2.9 (27.2 g, 93%) as a clear colorless oil. 1H 
NMR (500 MHz, CDCl3): δ 7.56 (dddd, J = 7.9, 1.6, 0.8, 0.8 Hz, 1H), 7.47 (dddd, J = 7.7, 
1.6, 1.0, 1.0 Hz, 1H), 7.26 (t, J = 7.8 Hz, 1H), 4.65 (dd, J = 1.0, 0.8 Hz, 2H), 1.01 (s, 9H), 
0.18 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 146.8, 131.1, 130.6, 129.4, 125.6, 102.7, 
71.4, 26.2, 18.6, –5.1;  HRMS (ES+): Calcd for (M+H)+: 426.9590. Found m/z: 426.9581; 
IR (thin film): 2954 (s), 2928 (s), 2883 (m), 2856 (s), 1256 (s), 1136 (s), 1105 (s)  cm–1. 
 
 
 
Ester 2.12: 
Aryl iodide 2.9 (47.04 g, 110 mmol), PPh3 (5.77 g, 22 mmol) and Et3N (76.57 mL, 549 
mmol) were sparged with argon for 30-40 min.  Ethyl acrylate (23.91 mL, 219.9 mmol) 
and Pd(OAc)2 (3.7 g, 16.49 mmol) were added to the mixture.  The reaction vessel was 
sealed with a Teflon®-lined cap and placed in a pre-heated oil bath at 85 °C for 8 h.  The 
Br
I
TBSO
Br
CO2Et
TBSO
! 92!
reaction was stopped at ca. 82% conversion based on NMR.  The crude material was 
filtered through a pad of Celite®. The residue was purified by flash chromatography 
(hexanes to 100:1 to 40:1 = hex:Et2O), affording the cinnamate ester 2.12 [32.43 g, 
73.8% (brsm 90%)] and the starting material, aryl iodide 2.9 (7.1 g, 15% recovered SM) 
as a clear colorless oil.  1H NMR (500 MHz, CDCl3): δ 7.80 (d, J = 16.3 Hz, 1H), 7.54 
(dd, J = 8.0, 1.3 Hz), 7.48 (dddd, J = 8.0, 1.3, 0.6, 0.6 Hz, 1H), 7.20 (t, J = 7.8 Hz, 1H), 
6.28 (d, J = 16.3 Hz, 1H), 4.67 (s, 2H), 4.29 (q, J = 7.1 Hz, 2H), 1.35 (t, J = 7.1 Hz, 3H), 
0.94 (s, 9H), 0.13 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 166.3, 141.9, 141.5, 134.2, 
132.0, 129.8, 127.4, 125.9, 123.9, 63.6, 60.9, 26.0, 18.5, 14.5,  –5.1; HRMS (CI+): Calcd 
for (M+H)+: 399.1001. Found m/z: 399.0991; IR (thin film, neat): 2955 (s), 2929 (s), 2856 
(s), 1722 (s), 1644 (m), 1179 (s) cm–1. 
 
 
Allyl Alcohol S2.3: 
The ester 2.12 (64.27 g, 160.9 mmol) was dissolved in THF (536.4 mL) and the resulting 
mixture was cooled to –78 °C.  DIBAL-H (482.8 mL, 1.0 M in hexanes, 482.8 mmol) was 
added and after being stirred for 1 h, the reaction mixture was first quenched with EtOAc 
and then half-saturated aqueous Rochelle’s salt.  After being stirred for a further 2 h, the 
mixture was extracted with Et2O.  The combined organics were washed with brine, dried 
over MgSO4 filtered and concentrated in vacuo.  The residue was purified by flash 
chromatography (10:1 = hex:EtOAc) affording allylic alcohol S2.3 (52.6 g, 91.5%) as a 
clear colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.505 (dd, J = 7.9, 1.4 Hz, 1H), 7.493 
(dd, J = 7.9, 1.4 Hz, 1H), 7.14 (t, J = 7.8 Hz, 1H), 6.61 (ddd, J = 16.2, 1.8, 1.8 Hz, 1H), 
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6.03 (dt, J = 16.2, 5.3 Hz, 1H), 4.71 (s, 2H), 4.38 (ddd, J = 6.0, 5.3, 1.8 Hz, 2H), 1.53 (br 
s, 1H). 0.94 (s, 9H), 0.12 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 141.3, 136.0, 135.9, 
131.3, 128.4, 127.2, 126.6, 123.9, 63.6, 63.4, 26.0, 18.5, –5.1;  HRMS (CI+): Calcd for 
(M–OH)+: 339.0780. Found m/z: 339.0761; IR (thin film, neat): 3345 (br, m) 2953 (s), 
2930 (s), 2857 (s), 1130 (s), 839 (s) cm–1. 
 
 
Epoxy Alcohol (–)-2.13: 
Molecular sieves (3Å, 310 mg) were placed in a round-bottom flask, which was flame-
dried 3 times under vacuum. (–)-DIPT (45.86 g, 195.8 mmol) and CH2Cl2 (593 mL) were 
added to the flask and the mixture was cooled to –45 °C.  Ti(Oi-Pr)4 (46.23 mL, 156.61 
mmol) was added to the mixture and the solution was stirred for 20 min.  t-BuOOH (89 
mL, 5 M in decane, 444.93 mmol; pre-treated with 4Å molecular sieves for 12 h) was 
added to the mixture, which was stirred for 40 min. at -45 °C.  Allylic alcohol S2.3 (63.6 
g, 177.97 mmol) in CH2Cl2 (119 mL) was added to the reaction mixture, which was 
placed in a –30 °C freezer for 48 h.  The reaction mixture was quenched with aqueous 
citric acid (10%, 800 mL) at 0 °C and the resulting mixture was stirred for 40 min at 0 °C.  
The aqueous layer was extracted with CH2Cl2.  The combined organics were dried over 
MgSO4, filtered and concentrated in vacuo.  The residue was purified by flash 
chromatography (hexanes to 10:1 = hex:EtOAc) affording the epoxy alcohol (–)-2.13 
(62.99 g, 94.9%, 92% ee by SFC) as a clear colorless oil.  1H NMR (500 MHz, CDCl3): δ 
7.54 (dddd, J = 7.7, 1, 1, 1 Hz, 1H), 7.44 (dd, J = 8, 1 Hz, 1H), 7.19 (dd, J = 7.9, 7.9 Hz, 
1H), 5.00 (d, J = 14.5 Hz, 1H), 4.94 (d, J = 14.5 Hz, 1H), 4.14 (ddd, J = 12.7, 5.1, 2.5 Hz, 
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1H), 3.99 (d, J = 2.2 Hz, 1H), 3.93 (ddd, J = 12.7, 7.8, 3.9 Hz, 1H), 3.22 (ddd, J = 3.9, 
2.5, 2.5 Hz, 1H), 1.92 (dd, J = 7.8, 5.1 Hz, 1H), 0.96 (s, 9H), 0.13 (s, 3H), and 0.12 (s, 
3H); 13C NMR (125 MHz, CDCl3): δ 144.0, 132.4, 131.0, 129.5, 125.8, 122.9, 62.4, 61.4, 
60.5, 55.8, 26.1, 18.6, –5.08, –5.14; HRMS (CI+): Calcd for (M+H)+: 373.0835. Found 
m/z: 373.0810; IR (thin film, neat): 3404 (br, w), 2930 (m), 2857 (m), 1134 (m), 838 (s) 
cm–1; 
€ 
α[ ]D
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 = –20.9 (c = 1.0, CHCl3). 
 
 
 
Carbamate S2.4: 
Preparation of benzoyl isocyanate:  
Benzamide (46.35 g, 382.5 mol) and CH2Cl2 (765 mL) were added to a flask equipped 
with a reflux condenser.  The heterogeneous mixture was stirred for 2 min and  (COCl)2 
(50.05 mL, 573.5 mmol) was added to the suspension at room temperature, which 
turned to a homogeneous clear solution.  A drying tube was attached to the condenser 
and the reaction mixture was warmed to 85 °C for 18 h.  The reaction mixture was 
cooled to ambient temperature and concentrated in vacuo.  Excess (COCl)2 was 
removed via azeotropic evaporation with PhH (2X) and the resulting solid was dried 
under vacuum for 0.5 h. 
The epoxy alcohol (–)-2.13 (60.36 g, 161.6 mmol) was dissolved in CH2Cl2 (648 mL) and 
the mixture was cooled to 0 °C.  Benzoyl isocyanate (80.48 mL, 3.0 M in CH2Cl2) was 
added to the mixture at 0 °C, which was stirred for 30 min at 0 °C and warmed to rt.  
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After being stirred for 30 min, the reaction mixture was quenched with H2O (50 mL).  The 
resulting mixture was extracted with CH2Cl2, washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo.  The residue was purified by flash chromatography 
(5:1 to 3:1 = hex:EtOAc) affording the epoxy carbamate (–)-S.4 (78.1 g, 92.9%) as a 
clear colorless oil. 1H NMR (500 MHz, CDCl3): δ 8.25 (s, 1H), 7.85 (d, J = 8.5 Hz, 1H), 
7.84 (d, J = 8.4 Hz, 1H), 7.60 (dddd, J = 8, 6.9, 1.3, 1.3 Hz, 1H), 7.55 (dddd, J = 7.8, 1.1, 
1.1, 1.1 Hz, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 7.7 Hz, 1H), 7.44 (dd, J = 8.0, 1.2 
Hz, 1H), 7.21 (ddd, J = 7.9, 7.9, 0.5 Hz, 1H), 4.99-4.95 (m, 2H), 4.93 (dd, J =12.3, 2.4 
Hz, 1H), 4.26 (dd, J = 12.4, 6.4 Hz, 1H), 3.96 (d, J = 2.3 Hz), 3.34 (ddd, J = 6.4, 2.3, 2.3 
Hz, 1H), 0.96 (s, 9H), 0.130 (s, 3H), 0.128 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 164.9, 
150.7, 144.0, 133.3, 133.0, 131.6, 131.0, 129.8, 129.1 (2), 127.8 (2), 125.9, 122.9, 66.0, 
62.3, 57.5, 56.4, 26.1, 18.6, –5.10, –5.14; HRMS (ESI): Calcd for (M+H)+: 542.0974. 
Found m/z: 542.0953; IR (thin film, neat): 3285 (br, w), 2953 (m), 2849 (m), 1763 (s), 
1693 (w), 1518 (s), 1194 (s) cm–1;
€ 
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 = –8.47 (c = 0.353, CHCl3). 
 
 
 
 
Oxazolidinone (+)-2.8: 
The epoxy carbamate (–)-S2.4 (72.6 g, 139.48 mmol) was dissolved in CH2Cl2 (558 mL), 
then H2O (558 mL) was added.  Bu4NCl (11.63 g, 41.844 mmol) and K2CO3 (38.56 g, 
278.96 mmol) were added to the solution.  The reaction vessel was closed with a 
Teflon®-lined cap and vigorously stirred for 71 h.  The mixture was diluted with H2O, and 
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the resulting mixture was extracted with CH2Cl2.  The combined organics were washed 
with brine, dried over MgSO4, filtered and concentrated in vacuo.  The residue was 
purified by flash chromatography (6:1 to 4:1 = hex:EtOAc) affording oxazolidinone (+)-
2.8 (67.9 g, 93.5%) as a clear colorless oil.  1H NMR (500 MHz, CDCl3): δ 8.061 (d, J = 
8.3 Hz, 1H), 8.058 (d, J = 8.4 Hz, 1H), 7.60 (dddd, J = 7.8, 7.0, 1.3, 1.3 Hz, 1H), 7.56 
(dd, J = 8, 1.3 Hz, 1H), 7.53 (dd, J = 7.8, 1.3 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.46 (d, J 
= 8.1 Hz, 1H), 7.22 (dd, J = 7.9, 7.9 Hz, 1H), 4.64 (s, 1H), 5.13, (d, J = 13.2 Hz, 1H), 
4.97 (s, 1H), 4.89 (m, 1H), 4.64 (dd, J = 9.2, 7.9 Hz, 1H), 4.47 (dd, J = 9.2, 4.6 Hz, 1H), 
0.95 (s, 9), 0.15 (s, 3H), 0.13 (s, 3H);  13C NMR (125 MHz, CDCl3): δ 165.4, 158.5, 
133.9, 132.3, 131.6, 130.7, 130.1 (2), 129.08, 129.02, 128.9 (3), 123.8, 68.7, 63.9, 63.0, 
54.0, 26.1, 18.6, –5.08, –5.1; HRMS (ESI/TOF): Calcd for (M+H)+: 542.0974. Found m/z: 
542.1001; IR (thin film, neat): 3253 (br, w), 2954 (m), 2928 (m), 1763 (s), 1727 (s), 1263 
(br, s) cm-1; 
€ 
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 = +41.9 (c = 4.73, CDCl3). 
 
 
 
 
Indoline S2.5: 
Note: The purity of the starting material (+)-2.8 is critical.   
To a round bottomed flask containing flame-dried (3x) Cs2CO3 (124.98 g, 383.58 mmol),  
P(o-tol)3 (62.26 g, 20.45 mmol), Pd2(dba)3 (5.88 g, 10.23 mmol), and aryl bromide (+)-
2.8 (66.55 g, 127.86 mmol) were added.  The mixture was dissolved in PhMe (639 mL, 
0.2 M; degassed by purging with argon for 20 minutes prior to use) and the reaction 
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vessel was closed with a Teflon®-lined cap and heated to 90 °C for 1.5 h.  After being 
cooled back to room temperature, the crude reaction mixture was filtered through Celite 
with EtOAc and the filtrate was concentrated.  The residue was purified by flash 
chromatography (7:1 to 5:1 = hex:Et2O) affording indoline (+)-S2.5 (52 g, 92.5%), 
contaminated with dibenzylideneacetone (dba).  The impure indoline (51.8 g, 117.84 
mmol) and CeCl3 (8.78 g, 23.57 mmol) were dissolved in MeOH (29.5 mL) and THF 
(58.9 mL). The resulting solution was cooled to 0 °C.  NaBH4 (1.27 g, 47.14 mmol) was 
added to the solution. The resulting mixture was filtered through a plug of Celite washed 
with MeOH and EtOAc.  The mixture was concentrated in vacuo and solidified upon 
treatment with hexanes, which was filtered to yield the pure indoline (+)-S2.5.  The 
filtrate was concentrated in vacuo and purified with flash chromatography (10:1 
hex:EtOAc) to afford the indoline (+)-S105 (combined yield, 44 g, 78.6%). 1H NMR (500 
MHz, CDCl3): δ 8.063 (d, J = 8.2 Hz, 1H), 8.061 (d, J = 8.4 Hz, 1H), 7.64 (dddd, J = 7.8, 
7.0, 1.3, 1.3 Hz, 1H), 7.50 (d, J = 8.3 Hz, 1H), 7.484 (d, J = 8.3 Hz, 1H), 7.478 (d, J = 7.9 
Hz, 1H), 7.44 (dd, J = 7.8, 7.8 Hz, 1H), 7.29 (dddd, J = 7.4, 1, 1, 1 Hz, 1H), 6.31 (d, J = 
5.8 Hz, 1H), 4.95, (ddd, J = 13.6, 8.3, 5.8 Hz),  4.89 (d, J = 13.5 Hz, 1H), 4.84 (d, J = 
13.5 Hz, 1H), 4.64 (dd, J = 13.6, 8.6 Hz, 1H), 4.47 (dd, J = 8.6, 5.8 Hz, 1H), 0.88 (s, 9H), 
0.37 (s, 3H), and 0.006 (s, 3H);  13C NMR (125 MHz, CDCl3): δ 167.4, 156.4, 141.6, 
140.3, 134.2, 131.4, 130.0, 129.1 (2), 129.0 (2), 126.1, 123.6, 114.9, 82.2, 70.1, 67.5, 
62.7, 26.1, 25.9, 18.6, –5.2, –5.3; HRMS (ESI): Calcd for (M+Na)+: 462.1713. Found: 
m/z: 462.1720; IR (thin film, neat): 2928 (m), 1771 (s), 1717 (s), 1266 (s), and 1109 (s) 
cm–1; 
€ 
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 = +107.1° (c = 1.0, CDCl3). 
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Alcohol S2.6: 
Benzoate (+)-S2.5 (43.3 g, 98.5 mmol) was dissolved in THF (3940 mL) and the mixture 
was cooled to –78 °C.  MeLi (147.8 mL, 1.6 M in ether, 236.4 mmol) was added in a 
dropwise manner.  The reaction was monitored by TLC and upon consumption of the 
starting material, the reaction mixture was quenched with EtOAc and pH 7 buffer.  The 
resulting mixture was extracted with EtOAc, washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo.  The residue was purified by flash chromatography 
(5:1 to 2:1 = hex:EtOAc) affording alcohol (–)-S.6 (26.55 g, 81.2%) as a clear colorless 
oil. 1H NMR (500 MHz, CDCl3): δ 7.44 (dd, J = 7.9, 1.0 Hz, 1H), 7.30 (dd, J = 7.8, 7.8 Hz, 
1H), 6.96 (dddd, J = 7.6, 1.0, 0.7, 0.7 Hz, 1H), 5.59 (d, J = 6.2 Hz, 1H), 4.89 (d, J = 12.9 
Hz, 1H), 4.84 (dd, J = 8.9, 8.9 Hz, 1H), 4.78 (d, J = 12.9 Hz, 1H), 4.69 (ddd, J = 8.8, 8.0, 
6.2 Hz, 1H), 4.37 (dd, J = 9.0, 8.0 Hz, 1H), 0.93 (s, 9H), 0.18 (s, 3H), and 0.14 (s, 3H); 
13C NMR (125 MHz, CDCl3): δ 156.6, 141.4, 137.7, 133.7, 130.2, 124.0, 115.7, 78.6, 
69.4, 67.6, 65.3, 26.0, 18.4, –5.1; HRMS (ESI/TOF): Calcd for (M+Na)+: 358.1445. 
Found m/z: 358.1465; IR (thin film, neat): 3415 (br, m), 2954 (m), 2929 (m), 1747 (s), 
1460 (s), 837 (s) cm–1; 
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 = –53.8° (c = 2.0, CDCl3). 
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TIPS ether (+)-2.35: 
The alcohol (–)-S2.6 (27.2 g, 81.08 mmol) and 2,6-lutidine (28.3 mL, 243.2 mmol) were 
dissolved in CH2Cl2 (162 mL) and the solution was cooled to 0 °C.  TIPSOTf (32.7 mL, 
121.6 mmol) was added to the mixture, which was subsequently warmed to rt.  After 
being stirred for 48 h, the reaction mixture was quenched with saturated aqueous 
NaHCO3 and extracted with CH2Cl2.  The combined organics were washed with brine, 
dried over MgSO4, filtered and concentrated in vacuo.  The residue was purified by flash 
chromatography (15:1 to 13:1 = hex:EtOAc) affording the silyl ether (+)-2.35 (39 g, 
97.8%) as a clear colorless oil. 1H NMR (500 MHz, CDCl3): δ 7.37 (br s, 3H), 5.77 (d, J = 
5.9 Hz, 1H), 4.99 (d, J = 14.4 Hz, 1H), 4.85 (d, J = 14.4 Hz, 1H), 4.79 (dd, J = 8.8, 8.8 
Hz, 1H), 4.65 (ddd, J = 8.6, 8.6, 5.9 Hz, 1H’), 4.35 (dd, J = 8.7, 8.7 Hz, 1H), 1.17-1.10 
(m, 21H), 0.96 (s, 9H), and 0.11 (s, 6H); 13C NMR (126 MHz, CDCl3): δ 155.98, 140.62 
(2), 139.71, 130.29, 130.27, 122.70, 113.91, 80.59, 69.22, 68.45, 61.81, 26.11, 18.59, 
18.42, 18.35, 13.20, –5.11; HRMS (ESI): Calcd for (M+Na)+: 514.2779. Found m/z: 
514.2795. IR (thin film, neat): 3410 (br w), 2947 (m), 2863 (m), 1777 (s), 1599 (w), 1459 
(s), 1390 (m), 1106 (m),836 (s) cm–1; 
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Iodide 2.35:  
Indoline (+)-2.34 (50 mg, 0.102 mmol) was dissolved in 0.5 mL of CH3CN and 0.5 mL of 
CH2Cl2.  AgNO3 (26 mg, 0.152 mmol) followed by I2 (39 mg, 0.152 mmol) were then 
added to generate an orange suspension. The reaction mixture was stirred for 5 h at rt, 
before the reaction mixture was quenched with saturated aqueous Na2S2O3 and 
extracted with CH2Cl2.  The combined organics were washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (6:1 to 3:1 = hex:EtOAc) affording the iodide (+)-2.35 (41 mg, 65%) as 
an off-white semisolid. 1H NMR (500 MHz, CDCl3): δ  7.82 (d, J = 8.3 Hz, 1H), 7.17 (d, J 
= 8.3 Hz, 1H), 5.94 (d, J = 4.6 Hz, 1H), 5.21 (d, J = 11.7 Hz, 1H), 4.81 (t, J = 8.8 Hz, 1H), 
4.71 (d, J = 11.7 Hz, 1H), 4.64 (ddd, J = 9.4, 8.7, 4.7 Hz, 1H), 4.26 (t, J = 9.2 Hz, 1H), 
1.12-1.11 (m, 21H), 0.88 (s, 9H), 0.12 (s, 3H), 0.09 (s, 3H), 0.08 (s, 6H); 13C NMR (126 
MHz, CDCl3): δ  156.32, 141.57, 141.48, 134.64, 116.64, 94.66, 79.25, 69.36, 68.20, 
65.99, 26.11, 18.47, 18.36, 18.31, 17.85, 13.21, 1.17, -4.25, -4.52; HRMS (ESI): Not 
Determined IR: Not Determined; 
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Benzylic Alcohol S2.7:  
TBS ether 2.35 (40 mg, 0.065 mmol) was dissolved in 0.6 mL of EtOH and 0.15 mL of 
CH2Cl2.  Camphorsulphonic acid (8 mg, 0.032 mmol) was added to the mixture and the 
reaction mixture was stirred for 24 h at rt.  The reaction mixture was quenched with 
saturated aqueous NaHCO3 and extracted with CH2Cl2.  The combined organics were 
washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The residue 
was purified by flash chromatography (6:1 = hex:EtOAc) affording 29 mg S.7 (91 %) as a 
yellow waxy solid. 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 1H), 7.08 (d, J = 8.3 
Hz, 1H), 5.92 (d, J = 5.8 Hz, 1H, 4.87 (d, J = 11.8 Hz, 1H), 4.74 (dd, J = 8.5, 8.5 Hz, 1H), 
4.74 (d, J = 11.8 Hz, 1H), 4.62 (ddd, J = 8.5, 8.5, 5.9 Hz, 1H), 4.33 (dd, J = 8.7, 8.7 Hz, 
1H), 2.53 (bs, 1H), 1.20-1.10 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 155.54, 141.39, 
141.21, 140.85, 134.54, 116.79, 95.14, 80.61, 69.11, 67.83, 65.31, 18.25, 18.15, 13.08; 
HRMS (ESI): Calcd for (M+H)+: 504.1062. Found m/z: 504.1064. IR (thin film, neat): 
3462 (br w), 2946 (m), 2867 (m), 1768 (s), 1647 (w), 1587 (w), 1477 (s), 1101 (s), 818 
(s) cm–1; 
€ 
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Aldehyde (+)-2.36: The benzyl alcohol SS.7 (29 mg, 0.058 mmol) was dissolved in 1.15 
mL CH2Cl2. NaHCO3 (10 mg, 0.115 mmol) and DMP (49 mg, 0.115 mmol) were added to 
the solution.  After being stirred for 30 min, the reaction mixture was diluted with 
saturated aqueous NaHCO3 and CH2Cl2 . The aqueous layer was extracted with CH2Cl2 
(3x) and the combined organics were dried over MgSO4, then filtered and concentrated 
in vacuo. The residue was purified by flash chromatography (6:1 to 3:1 = hex:EtOAc) 
affording 29 mg of (+)-2.36 (99 %) as a waxy yellow solid. 1H NMR (500 MHz, CDCl3): δ 
10.09 (s, 1H), 7.87 (d, J = 8.3 Hz, 1H), 7.31 (d, J = 8.3 Hz, 1H), 6.08 (d, J = 4.7 Hz, 1H), 
4.78 (dd, J = 8.8, 8.8 Hz, 1H), 4.64 (ddd, J = 9.1, 8.8, 4.7 Hz, 1H), 4.32 (dd, J = 9.1, 9.1 
Hz, 1H), and 1.16-1.01 (m, 21H); 13C NMR (125 MHz, CDCl3): δ 194.61, 156.08, 142.55, 
142.28, 136.91, 133.57, 121.16, 91.38, 78.02, 69.22, 68.73, 18.28, 18.26, and 12.78; 
HRMS (ESI): Calcd for (M+Na)+: 524.0724. Found m/z: 524.0722; IR (thin film, neat): 
3400 (br w), 2943 (m), 2865 (m), 1776 (s), 1700 (m), 1583 (w), 1447 (m), 1115 (m), and 
822 (m) cm–1; 
€ 
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Hydrazone (+)-2.37: 
Note: The purity of the starting materials, (+)-2.36 and (+)-2.6 is critical to achieve higher 
dr and yield.  
Hydrazone (+)-2.6 (0.502 g, 68.58 mmol) was dissolved in THF (685.8 mL, 0.1 M) and 
the solution was cooled to –78 °C.  t-BuLi (46.56 mL, 1.473 M in hexanes, 68.58 mmol) 
was added to the solution at –78 °C.  After being stirred for 1 h at -78 °C, the reaction 
mixture was cooled to –100 °C (liquid N2/EtOH bath).  Sc(OTf)3 (1.87 g, 3.81 mmol) was 
added to the aza-enolate solution, and the pre-cooled aldehyde (+)-2.36 (29.3 g, 38.1 
mmol, 1 equiv) in THF (165 mL, 0.23 M) at –78 °C was added to the reaction mixture via 
a cannular dropwise. After being stirred for 1 h at –100 °C, the reaction mixture was 
warmed to –78 °C and stirred for additional 1 h.  The mixture was quenched with pH 7 
buffer at –78 °C and the solution was slowly warmed to rt.  The resultant mixture was 
extracted with EtOAc, washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo.  The residue was purified by flash chromatography (3:1, then 1:1 = hex:EtOAc) 
affording hydrazone (+)-2.37 (19.412 g, 66.3%, 6.5:1 dr) and recovered the aldehyde 
(+)-2.36 (2.852 g, 14.9%). 1H NMR (500 MHz, CDCl3, 320K): δ 7.88 (d, J = 8.4 Hz, 1H), 
7.21 (d, J = 8.4 Hz, 1H), 6.49 (d, J = 4.0 Hz, 1H), 5.51 (dd, J = 8.8, 8.8 Hz, 1H), 4.97 (d, 
J = 8.8 Hz, 1H), 4.80 (dd, J = 8.6, 8.6 Hz, 1H), 4.69 (ddd, J = 9.1, 8.6, 4.4 Hz, 1H), 4.32 
(dd, J = 9.1, 8.6 Hz, 1H), 3.54 (d, J = 8.8 Hz, 1H), 3.25-3.14 (m, 1H), 3.20 (s, 3H), 3.07 
(d, J = 13.0 Hz, 1H), 3.08-3.00 (m, 1H), 2.87-2.80 (m, 1H), 2.60-2.51 (m, 1H), 2.59-2.53 
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(ddd, J = 8.8, 9.0, 9.2 Hz, 1H), 2.15 (d, J = 13.0 Hz, 1H), 2.09-2.01 (m, 1H), 1.90-1.81 
(m, 1H), 1.78-1.71 (m, 1H), 1.65 (s, 3H), 1.45 (s, 3H), 1.38-1.33 (m, 1H), 1.16 (s, 6H), 
1.16-1.10 (m, 21H);  13C NMR (125 MHz, CDCl3): δ 162.5, 155.61, 144.29, 142.68, 
142.51, 132.86, 116.60, 80.90, 78.86, 77.57, 75.42, 75.33, 69.03, 68.08, 66.62, 59.09, 
55.59, 54.00, 44.73, 34.07, 32.07, 29.81, 28.76, 27.35, 22.47, 18.39, 18.31, and 14.07; 
HRMS (ESI): Calcd for (M+H)+: 770.3056. Found m/z: 770.3062; IR (thin film, neat): 
3395 (br m), 2948 (m), 2869 (m), 1779 (s), 1637 (m), 1570 (w), 1442 (m), 1101 (m), 730 
(m) cm–1; MP: 159-160 °C; 
€ 
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24
 = +114° (c = 1.31, CDCl3) 
 
 
 
Enone (+)-3.32: 
In a round bottom flask, 4 Å molecular sieves (50 g) were activated by flame drying 
under vacuum. Ketone (+)-3.5 (100 g, 560 mmol) was dissolved in ethylene glycol (1.8 
L). p-Toluenesulfonic Acid monohydrate (106.5 g, 560 mmol) was then added and the 
solution was stirred for 16 hours. The reaction was poured into NaHCO3 and ice, then 
the solids were filtered through Celite and the filter cake was washed with EtOAc. The 
aqueous fraction was then extracted with EtOAc. The combined organics were then 
dried over MgSO4 and concentrated in vacuo. The crude mixture was filtered through a 
plug of silica gel with 2:1 (hex:EtOAc) and concentrated to give 107.3 g (82 %) of (+)-
3.32  as an oil. 1H NMR (500 MHz, CDCl3): δ  4.02-3.91 (m, 4H), 2.77-2.72 (m, 1H), 
2.51-2.37 (m, 2H), 2.28-2.21 (m, 1H), 2.16 (dddd, J = 15.3, 13.7, 5.6, 1.5 Hz, 1H), 1.90 
(td, J = 13.4, 4.6 Hz, 1H), 1.84-1.81 (m, 1H), 1.79 (d, J = 1.5 Hz, 3H), 1.72-1.61 (m, 3H), 
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1.34 (d, J = 0.6 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ  198.82, 160.23, 130.31, 112.93, 
65.49, 65.22, 45.44, 33.85, 29.88, 26.66, 26.61, 21.58, 21.02, 11.63. 
 
 
 
Alcohol (+)-3.33: 
A 500 mL 3-neck round bottom flask equipped with a cold finger was cooled to –78 °C. 
Then, ammonia gaswas condensed into the flask (325 mL) and lithium metal (1.26 g, 
182.0 mmol) was dissolved to generate a deep blue solution. In a separate flask, ketal 
(+)-3.32 (8.6g, 36.4 mmol) and t-BuOH (3.5 mL, 36.4 mmol) were dissolved in THF (130 
mL). The ketal solution was cannulated into the Li/NH3 solution then the reaction was 
allowed to stir at –78 °C for 1 hr. The reaction was then quenched with isoprene (10.9 
mL, 109.2 mmol) over 30 min to generate a colorless solution (Exothermic addition, slow 
addition critical!). The solution was first warmed to 0 °C, then room temperature under a 
strong stream of N2 to begin removing NH3. To remove the remainder of the NH3, 
aspirator vacuum was applied to the solution to give the lithium enolate as a white 
semisolid. Following backfilling the flask with N2, the solid was dissolved in THF (110 
mL) and cooled to 0 °C. In a separate flask, TMSCl (25.4 mL, 200.2 mmol) and Et3N 
(28.0 mL, 200.2 mmol) were dissolved in THF (130 mL). The TMSCl solution was added 
to the enolate and the suspension stirred for 45 min. The reaction was then poured into 
saturated aqueous NaHCO3 and extracted with Et2O. The organics were dried over 
MgSO4 and concentrated in vacuo to give 9.5 g of the TMS enol ether as a yellow oil.  
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TMS enol ether (9.5 g, 30.6 mmol), formaldehyde (238 mL, 37 wt% in H2O), and 
NaHCO3 (126 mg, 84.0 mmol) were dissolved in THF (550 mL). Sc(OTf)3 (738 mg, 1.5 
mmol) was then added and the solution was stirred for 1 hr. The reaction was then 
poured into saturated aqueous NaCl and extracted with EtOAc. The organics were 
washed with brine, dried over MgSO4 and concentrated in vacuo. Flash chromatography 
(5:1 = hex:EtOAc) gave 8.0 g (82 %) of alcohol (+)-3.33 as a semisolid. 1H NMR (500 
MHz, CDCl3): Not Determined; 13C NMR (125 MHz, CDCl3): Not Determined; HRMS 
(ESI): Calcd for (M+Na)+: Not Determined; IR (thin film, neat): Not Determined;  = 
Not Determined 
 
 
Ketone (+)-3.4: 
NMe4BH(OAc)3 (36.5 g, 139.0 mmol) was dissolved in CH3CN (123 mL) and AcOH (123 
mL) , then the suspension was cooled to –30 °C in a NaCl/ice bath. Ketone (+)-3.33 
(7.46 g, 27.8 mmol) was dissolved in CH3CN (60 mL), then added to the suspension and 
stirred for 2 hours at –30 °C. The reaction was then warmed to room temperature, stirred 
for 4 hours, and then poured into saturated aqueous NaHCO3. The aqueous fraction was 
extracted with EtOAc. The organic layers were dried over Na2SO4 and concentrated in 
vacuo to give the diol as a mixture of the ketal and the ketone.  
 
The mixture was dissolved in THF (150 mL) and 1N HCl (70 mL). The reaction was 
allowed to stir overnight, and then poured into saturated aqueous NaHCO3. The 
aqueous layer was extracted with EtOAc. The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo. The residue was purified by flash chromatography 
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(1:1 = hex:EtOAc) affording 3.8 g (62 %) of the ketodiol as a white solid. 1H NMR (500 
MHz, CDCl3): δ  3.70 (d, J = 10.5 Hz, 1H), 3.62 (dd, J = 10.7, 4.5 Hz, 1H), 3.41 (d, J = 
10.5 Hz, 1H), 2.57 (td, J = 14.0, 6.9 Hz, 3H), 2.22 (dd, J = 14.1, 4.9 Hz, 1H), 2.07 (td, J = 
6.6, 2.6 Hz, 1H), 1.77-1.70 (m, 2H), 1.63 (q, J = 7.0 Hz, 3H), 1.58-1.52 (m, 1H), 1.35 (dd, 
J = 12.3, 2.8 Hz, 1H), 1.19 (s, 3H), 0.97 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 215.47, 
75.06, 70.09, 48.35, 46.72, 42.97, 37.55, 31.07, 26.38, 26.04, 20.83, 19.05, 11.92. 
 
The diol (3.8 g, 16.8 mmol)  and 2,6-lutidine (9.8 mL, 84 mmol) was dissolved in CH2Cl2 
(168 mL) and cooled to 0 °C. TBSOTf (7.75 mL, 33.6 mmol) was then added and the 
reaction was warmed to room temperature for 3 hours. Saturated aqueous NaHCO3 was 
added to the reaction followed by extracting with CH2Cl2. The combined organics were 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
chromatography (20:1 = hex:Et2O) affording 6.0 g (79 %) of ketone (+)-3.4 as a white 
solid. 1H NMR (500 MHz, CDCl3): δ    3.66 (dd, J = 10.5, 4.6 Hz, 1H), 3.43 (d, J = 9.8 Hz, 
1H), 3.15 (d, J = 9.8 Hz, 1H), 2.56 (td, J = 13.9, 6.9 Hz, 1H), 2.20 (dd, J = 14.1, 3.9 Hz, 
1H), 2.07-2.04 (m, 1H), 1.69-1.52 (m, 8H), 1.16 (s, 3H), 0.88 (s, 9H), 0.87 (s, 9H), 0.71 
(s, 3H), 0.06 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H). 
 
 
Enal (+)-3.3: 
Ketone (+)-3.4 (7.9 g, 17.37 mmol) was dissolved in THF (175 mL) then cooled to –78 
°C. KHMDS (52 mL, 0.5M in PhMe, 26.1 mmol) was then added and the solution was 
stirred at –78 °C for 1 hour. Phenyltriflamide (8.7 g, 24.32 mmol) was added as a solid 
and the reaction was warmed to room temperature after 45 min. The reaction was 
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poured into saturated aqueous NH4Cl and then extracted with Et2O. The organics were 
washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash chromatography (100% hex to 50:1 = hex:Et2O) affording vinyl triflate 
(9.6 g, 94%) as a yellow oil. 1H NMR (500 MHz, CDCl3): δ  5.56 (dd, J = 5.0, 2.8 Hz, 1H), 
3.77 (dd, J = 11.4, 4.9 Hz, 1H), 3.44 (d, J = 9.9 Hz, 1H), 3.19 (d, J = 9.8 Hz, 1H), 2.25-
2.19 (m, 1H), 2.16-2.09 (m, 1H), 1.81-1.69 (m, 4H), 1.64-1.57 (m, 3H), 1.44-1.36 (m, 
2H), 1.30-1.27 (m, 1H), 1.18 (s, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.64 (s, 3H), 0.06 (s, 3H), 
0.05 (d, J = 0.9 Hz, 6H), 0.04 (s, 3H). 
 
Lithium Chloride (1.4 g, 34 mmol) was dried in a 3-neck round bottom flask overnight 
under high-vacuum at 100 °C. To the flask, the vinyl triflate (10.0 g, 17.0 mmol) and THF 
(170 mL) were added. The flask was equipped with a reflux condenser and an addition 
funnel. Carbon monoxide was then bubbled through the solution for 30 min. Pd(PPh3)4 
(1.4 g, 1.19 mmol) was then added and the solution was heated to 50 °C. Bu3SnH (6.9 
mL, 25.5 mmol) was dissolved in THF (170 mL) and added to the addition funnel. The 
funnel was covered in foil. The Bu3SnH solution was added dropwise to the reaction over 
2 hours. The reaction was then cooled to room temperature and KF/Celite was added. 
The suspension was stirred for 2 hour, then filtered through celite and concentrated in 
vacuo. The residue was purified by flash chromatography (8:1 = hex:EtOAc) affording 
enal (+)-3.3 (6.4 g, 81%) as a white solid. 1H NMR (500 MHz, CDCl3): δ  9.30 (s, 1H), 
6.57 (dd, J = 4.6, 2.7 Hz, 1H), 3.74 (dd, J = 11.3, 5.3 Hz, 1H), 3.45 (d, J = 9.8 Hz, 1H), 
3.20 (d, J = 9.8 Hz, 1H), 2.64 (dt, J = 13.5, 3.6 Hz, 1H), 2.44 (dt, J = 20.4, 4.8 Hz, 1H), 
2.34-2.26 (m, 1H), 1.69-1.64 (m, 3H), 1.56 (dt, J = 7.5, 2.7 Hz, 1H), 1.42 (d, J = 31.8 Hz, 
2H), 1.17 (s, 3H), 0.89 (d, J = 3.9 Hz, 18H), 0.64 (s, 3H), 0.06-0.04 (m, 12H); 13C NMR 
! 109!
(125 MHz, CDCl3): δ  157.22, 114.77, 71.28, 64.35, 43.38, 43.14, 38.83, 32.48, 27.19, 
26.05, 24.60, 19.72, 18.22, 17.53, 12.89, -3.43, -4.78, -5.17, -5.67. 
 
 
 
 
Aldehyde (–)-3.23:  
Preparation of CuBr•SMe2: 
Prepared as described in Synth. Comm., 1981, 157-166 
CuBr2 (10 g) was dissolved in 10  mL of water to give a deep blue solution, to which a 
solution of Na2SO3 (7.6 g) in 50 mL water was added. The resulting solution was stirred 
for 20 min to generate a white suspension. The CuBr suspension was poured into a 
solution of 2 mL of conc. HCl and 1 g Na2SO3 in 800 mL and stirred for 15 min. The 
suspension was settled and the water was decanted off. The solids were then 
transferred to a Büchner funnel with 0.1M H2SO4. The solids were then washed with 
glacial acetic acid, EtOH, and Et2O. The off-white powder was dried, then dissolved in a 
minimum amount of dimethyl sulfide. CuBr•SMe2 was crashed out of solution as a white  
powder with hexanes. The solids were collected by filtration and should be air-dried in a 
desiccator.  
 
Preparation of vinyl magnesisum bromide solution: 
Vinyl bromide was bubbled through THF (50 mL) until 8.0 g had been dissolved in the 
solvent. Magnesium turnings (1.6 g) was added to a three-neck flask, fitted with a stirbar, 
cold finger and addition funnel. The vinyl bromide solution was added the addition funnel 
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and ~3 mL of the solution was added to the magnesium turnings. The reaction was 
gently warmed until the solvent turned faint orange and bubbling was observed. The 
remainder of the vinyl bromide was added dropwise over a 30 min period. The solution 
was then heated to reflux for 30 min. The reaction mixture was then diluted with another 
50 mL of THF while the reaction was still warm. To ensure that vinylmagnesium bromide 
did not precipitate out of solution. The concentration of the solution was then determined 
using Love’s reagent. 
 
CuBr•SMe2(5.5 g, 27.0 mmol), 63 mL of THF and 63 mL of dimethyl sulfide were added 
to a flame-dried flask to generate a clear solution. The solution was then cooled to –78 
°C to give a white suspension. Vinylmagnesium bromide (99.9 mL, 0.54 M in THF, 54.0 
mmol) was added dropwise over 15 min. The suspension first turned brown/orange upon 
addition, then turned a dark green color. After 5 min, 3.13 mL of HMPA was  added, then 
the solution was stirred at –78 °C for 15 min. Separately, enal 3.3 (4.2 g, 9.0 mmol) and 
TMSCl  (2.28 mL, 18.0 mmol) were dissolved in 31 mL of THF. The enal solution was 
then added dropwise to the cuprate solution over 30 min. The solution was then stirred 
for 1 hr at –78 °C then slowly warmed to room temperature. The septa was then 
removed from the flask and water (5 mL) and TMEDA (3 mL) were then added and the 
suspension allowed to stir open to air for 1 hour. The suspension was diluted with 
hexanes and filtered through Celite. The organic layer was washed with brine (3x) and 
then the solvent was removed in vacuo. The resulting oil was then dissolved in hexanes 
and washed again with brine (3x). The organic layer was then dried over MgSO4 and 
concentrated in vacuo to give the TMS enol ether as a pale-green oil. The oil (4.9 g) was 
then heated in a 100 °C oil bath under high vacuum for 1 hour to remove any excess 
water.  
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The crude TMS enol ether (4.9 g, 8.64 mmol) was dissolved in THF (77 mL) and HMPA 
(8.6 mL) and cooled to 0 °C. MeLi (27 mL, 1.6M in Et2O, 43.2 mmol) was added 
dropwise over a 15 min period. The solution was then cooled to –78 °C and methyliodide 
(5.4 mL, 86.4 mmol) was added dropwise generating gas. The reaction was allowed to 
warm to room temperature and was then quenched with brine. The aqueous layer 
extracted with EtOAc. The combined organics were dried over MgSO4 and concentrated 
in vacuo. MPLC purification (100:1 = hex:EtOAc) gave 1.8 g (35 % from aldehyde (–)-
3.23) of waxy solid.  1H NMR (500 MHz, CDCl3): δ  9.69 (s, 1H), 5.61-5.56 (m, 1H), 5.01-
4.99 (m, 2H), 3.36 (d, J = 9.8 Hz, 1H), 3.13-3.11 (m, 1H), 3.06-3.02 (m, 1H), 1.90 (dd, J 
= 11.9, 4.0 Hz, 1H), 1.77-1.73 (m, 1H), 1.60-1.57 (m, 3H), 1.48-1.36 (m, 4H), 1.21 (s, 
3H), 1.02 (s, 3H), 0.93 (s, 9H), 0.87 (s, 9H), 0.64 (s, 3H), 0.04 (s, 12H); 13C NMR (125 
MHz, CDCl3): δ 209.06, 139.92, 115.69, 71.35, 64.07, 55.61, 43.68, 40.68, 40.49, 36.39, 
31.88, 26.91, 26.81, 25.90, 25.86, 20.98, 17.98, 17.02, 12.98, 10.05, -3.68, -4.94, -5.35, 
-5.74; HRMS (ESI): Calcd for (M+Na)+: Not Determined; IR (thin film, neat): 2927 (s), 
1712 (s), 1254 (m), 1084 (m), 836 (s), 772 (s), 668 (w) cm–1;  = –31.6° (c = 1.32, 
CDCl3). 
 
 
 
 
Diene S3.1: 
Aldehyde (–)-3.23 (171 mg, 0.34 mmol) was dissolved in 3.4 mL THF under N2. The 
solution was then cooled to –78 °C and 2.3 mL of vinylmagnesium bromide (0.45M in 
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THF) was added. The solution was allowed to warm to room temperature and quenched 
with brine. The aqueous layer was extracted with Et2O. The combined organic layers 
were dried over MgSO4 and concentrated in vacuo. MPLC purification (60:1 = 
hex:EtOAc) gave 178 mg (99 %) of S3.1 as an off-white semi-solid. 1H NMR (500 MHz, 
CDCl3): δ  6.03-5.96 (m, 2H), 5.10-5.00 (m, 4H), 4.20 (t, J = 7.4 Hz, 1H), 3.67 (dd, J = 
11.8, 4.5 Hz, 1H), 3.34 (d, J = 9.8 Hz, 1H), 3.12 (d, J = 9.7 Hz, 1H), 2.90-2.86 (m, 1H), 
1.95 (d, J = 11.5 Hz, 1H), 1.70-1.65 (m, 2H), 1.58-1.54 (m, 2H), 1.46-1.34 (m, 5H), 1.21 
(s, 3H), 0.92 (s, 9H), 0.88 (s, 9H), 0.86 (s, 3H), 0.63 (s, 3H), 0.05 (s, 3H), 0.04 (s, 6H), 
0.03 (s, 3H); 13C NMR (125 MHz, CDCl3): Not determined; HRMS (ESI): Not determined; 
IR (thin film, neat): Not determined ;  = –10.4° (c = 0.32, CHCl3). 
 
 
 
 
Allylic Alcohol S3.2: 
Diene S3.1 (105 mg, 0.196 mmol) was dissolved in CH2Cl2. Hoveyda-Grubbs second 
generation catalyst (6 mg, 0.01 mmol) was added and the solution was stirred for 4 
hours. The CH2Cl2 was then removed in vacuo from the crude reaction mixture. The 
mixture was then purified by MPLC (10:1 = hex:EtOAc) to give 65 mg (66 %) of an off-
white solid. 1H NMR (500 MHz, CDCl3): δ  5.94 (dd, J = 5.8, 1.7 Hz, 1H), 5.85 (dt, J = 
5.8, 2.9 Hz, 1H), 4.35 (d, J = 1.9 Hz, 1H), 3.71 (dd, J = 11.4, 4.6 Hz, 1H), 3.37 (d, J = 9.7 
Hz, 1H), 3.19 (d, J = 13.1 Hz, 1H), 3.09 (s, 1H), 2.15 (dd, J = 12.4, 3.0 Hz, 1H), 1.77-
1.54 (m, 9H), 1.40 (s, 3H), 0.91 (s, 9H), 0.89 (s, 3H), 0.88 (s, 9H), 0.65 (s, 3H), 0.06 (s, 
3H), 0.05 (s, 3H), 0.04 (s, 3H), 0.04 (s, 3H); 13C NMR (125 MHz, CDCl3): δ141.11, 
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133.33, 84.33, 72.12, 64.69, 51.63, 45.04, 43.71, 40.07, 37.81, 31.47, 27.78, 26.08, 
26.05, 23.95, 22.27, 18.88, 18.26, 18.10, 17.62, 13.03, -3.39, -4.76, -5.15, -5.57; HRMS 
(ESI): Calcd for (M+Na)+: 531.3666. Found m/z: 531.3669; IR (thin film, neat): 3414 (br 
w), 2927 (s), 2857 (s), 1472 (w), 1252 (m), 1085 (s), 835 (s), 773 (w) cm–1;  = +23° 
(c = 6.4, CDCl3) 
 
 
 
 
Enone S3.3: 
Allylic alcohol S3.2 (251 mg, 0.493 mmol) was dissolved in 10 mL of CH2Cl2. NaHCO3 
(165mg, 1.97 mmol) was added as a solid followed by the addition of Dess-Martin 
periodinane (418 mg, 0.98 mmol). The white suspension was stirred at room 
temperature for 1 hr and then quenched with saturated aqueous NaHCO3. The aqueous 
layer was extracted with CH2Cl2, the combined organic layers were dried over MgSO4 
and concentrated in vacuo. The crude reaction mixture was then filtered through a short 
pad of silica gel with (10:1 = hex:EtOAc) to give 239 mg (96 %) of S3.2 as a white semi-
solid. 1H NMR (500 MHz, CDCl3): δ  7.40 (dd, J = 5.9, 1.8 Hz, 1H), 5.89 (dd, J = 5.9, 3.2 
Hz, 1H), 3.69 (dd, J = 11.3, 5.2 Hz, 1H), 3.43 (d, J = 9.7 Hz, 1H), 3.10 (t, J = 10.0 Hz, 
2H), 2.12-2.00 (m, 3H), 1.86-1.82 (m, 1H), 1.68-1.58 (m, 5H), 1.51-1.46 (m, 1H), 1.33-
1.26 (m, 2H), 1.17 (s, 3H), 1.06 (s, 3H), 0.92 (s, 9H), 0.87 (s, 9H), 0.61 (s, 3H), 0.05 (d, J 
= 6.6 Hz, 12H); 13C NMR (125 MHz, CDCl3): δ  213.49, 162.82, 132.00, 72.01, 64.43, 
59.56, 47.15, 43.95, 38.73, 37.86, 30.32, 27.65, 26.08, 26.02, 23.36, 23.07, 20.04, 
18.88, 18.27, 18.11, 12.41, -3.32, -4.78, -5.08, -5.62; HRMS (ESI): Calcd for (M+Na)+: 
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507.3611. Found m/z: 507.3689;  IR (thin film, neat): 2926 (s), 1701 (s), 1086 (m), 835 
(m), 772 (w) cm–1;  = +8.3° (c = 1.0, CHCl3). 
 
 
 
 
Ketone (–)-3.31: 
Palladium on carbon 10 wt% (14 mg) was added to  4 mL of EtOAc, and hydrogen gas 
was bubbled through the suspension for 30 min. Enone S.3 (73 mg, 0.144 mmol) was 
then dissolved in 2 mL of EtOAc and added to the suspension. The reaction was allowed 
to stir under the pressure of a H2 balloon for 4 hours. The H2 atmosphere was replaced 
by an N2 atmosphere and the suspension was then filtered through Celite and 
concentrated in vacuo to give 65 mg (90 %) of (–)-3.31 as a white semi-solid. 1H NMR 
(500 MHz, CDCl3): δ  3.66 (dd, J = 11.5, 5.0 Hz, 1H), 3.40 (d, J = 9.7 Hz, 1H), 3.09 (d, J 
= 9.7 Hz, 1H), 2.31 (dd, J = 19.3, 8.1 Hz, 1H), 2.22-2.16 (m, 1H), 2.06 (dt, J = 13.3, 3.4 
Hz, 1H), 2.01 (dd, J = 19.1, 9.5 Hz, 1H), 1.88 (dd, J = 12.1, 3.0 Hz, 1H), 1.82-1.76 (m, 
1H), 1.69-1.45 (m, 7H), 1.35-1.25 (m, 2H), 1.00 (s, 3H), 0.92 (s, 8H), 0.92 (s, 3H), 0.87 
(s, 9H), 0.59 (s, 3H), 0.04 (d, J = 6.6 Hz, 12H); 13C NMR (125 MHz, CDCl3): δ  71.97, 
64.46, 56.18, 43.82, 40.53, 39.08, 37.74, 30.41, 27.51, 26.07, 26.05, 25.89, 23.92, 
22.18, 18.26, 18.14, 17.62, 12.48, 10.52, -3.39, -4.78, -5.11, -5.61; HRMS (ESI): Not 
Determined; IR (thin film, neat): 2954 (s), 2935 (s), 2856 (m), 1728 (s), 1471 (w), 1384 
(w), 1254 (m), 1087 (m), 835 (s), 772 (s) cm–1;  = –61° (c = 1.29, CDCl3). 
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Triflate S3.4: 
Ketone (–)-3.31 (30 mg, 0.059 mmol) was dissolved in 1.2 mL of THF under N2 and 
cooled to –78 °C. KHMDS (0.24 mL, 0.5M in PhMe) was then added and the solution 
was stirred for 20 min. Phenyl triflamide (44 mg, 0.124 mmol) was then added as a solid 
and the suspension was stirred at –78 °C for 30 min, then allowed to warm to room 
temperature. Brine was added and the aqueous layer was extracted with EtOAc. The 
combined organic layers were dried over MgSO4 and concentrated in vacuo. MPLC 
purification (200:1 = hex:EtOAc) gave 38 mg (99 %) of a clear oil. 1H NMR (500 MHz, 
CDCl3): δ  5.54 (dd, J = 3.1, 1.7 Hz, 1H), 3.67 (dd, J = 11.3, 5.1 Hz, 1H), 3.41 (d, J = 9.8 
Hz, 1H), 3.09 (d, J = 9.7 Hz, 1H), 2.31-2.24 (m, 1H), 2.17-2.13 (m, 1H), 1.98 (ddd, J = 
14.7, 11.1, 1.7 Hz, 1H), 1.89 (dd, J = 12.5, 3.2 Hz, 1H), 1.67-1.50 (m, 6H), 1.39-1.32 (m, 
1H), 1.28-1.21 (m, 1H), 1.08 (s, 3H), 1.04 (s, 3H), 0.92 (s, 9H), 0.88 (s, 9H), 0.60 (s, 3H), 
0.06-0.04 (m, 12H); 13C NMR (125 MHz, CDCl3): δ  158.68, 114.14, 71.81, 64.36, 54.73, 
43.96, 42.90, 38.88, 37.59, 30.99, 30.34, 27.78, 26.08, 26.05, 24.55, 22.71, 18.27, 
18.22, 18.12, 12.28, 12.09, -3.38, -4.75, -5.10, -5.61; HRMS (ESI): Calcd for (M+Na)+: 
641.3261. Found m/z: 641.3270; IR (thin film, neat):  2953 (s), 2857 (m), 1625 (w), 1423 
(m), 1250 (m), 1213 (s), 1142 (m), 1093 (m), 835 (s), 774 (m) cm–1;  = –2.5° (c = 
2.3, CDCl3). 
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Vinyl Bromide (–)-3.35: 
Pd2(dba)3 (9 mg, 0.010 mmol) and t-BuXPhos (13 mg, 0.031 mmol) were dissolved in 
0.7 mL of dioxane which had been degassed by sparging with argon for 30 min. The 
purple solution was heated to 120 °C for 3 min to give a deep orange-red solution. In a 
separate vial, triflate S3.4 (110 mg, 0.172 mmol), potassium bromide (41 mg, 0.343 
mmol) and potassium fluoride (5 mg, 0.086 mmol) were taken up in 1.0 mL of degassed 
dioxane. The palladium solution was then added to the vial, the vial was capped and 
stirred overnight at 125 °C. The black suspension was then diluted with hexanes, then 
washed with 1 N HCl followed by brine. The organic layer was dried over MgSO4 and 
concentrated in vacuo. The residue was purified by flash chromatography (100:1 = 
hex:EtOAc) affording vinyl bromide (–)-3.35 (87 mg, 89%) as an off-white solid.  1H NMR 
(500 MHz, CDCl3) δ  5.81-5.80 (m, 1H), 3.67 (dd, J = 11.4, 5.2 Hz, 1H), 3.41 (d, J = 9.7 
Hz, 1H), 3.10 (d, J = 9.7 Hz, 1H), 2.30-2.23 (m, 2H), 2.04 (ddd, J = 14.9, 6.6, 3.1 Hz, 
1H), 1.91-1.84 (m, 2H), 1.69-1.59 (m, 3H), 1.53-1.49 (m, 1H), 1.44-1.35 (m, 2H), 1.26 (d, 
J = 4.0 Hz, 1H), 1.09 (s, 3H), 0.94 (s, 3H), 0.93 (s, 9H), 0.88 (s, 9H), 0.60 (s, 3H), 0.06-
0.04 (m, 12H); 13C NMR (125 MHz, CDCl3): δ  133.69, 132.42, 71.90, 64.47, 57.54, 
44.29, 44.10, 39.77, 38.23, 33.82, 30.21, 27.75, 26.10, 26.07, 25.29, 22.96, 18.28, 
18.14, 17.68, 12.56, 12.33, 1.18, -3.37, -4.73, -5.09, -5.60; HRMS (ESI): Calcd for 
(M+H)+: 571.2924. Found m/z: 571.2927; IR (thin film, neat): 2929 (s), 1471 (w), 1254 
(w), 1090 (s), 835 (s), 773 (m) cm–1;  = —2.3° (c = 2.13, CDCl3). 
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Alternative method for generation of bromide (–)-3.35 
Ketone (–)-3.31 (80 mg, 0.157 mmol), bis-TBS hydrazine (102 mg, 0.393 mmol) and 
Sc(OTf)3 (15mg, 0.031 mmol) were added to a vial. A few drops of PhMe were added 
(just enough to dissolve ketone (–)-3.31), then the vial was sealed with a Teflon lined 
cap and heated to 75 °C for 12 hours. The reaction was cooled to room temperature and 
diluted with hexanes. The solids were filtered off and the organics were concentrated in 
vacuo. The residue was pumped on high vacuum for 12 hours. 
The crude hydrazine and pyridine (0.25 mL, 3.14 mmol) were dissolved in CH2Cl2 (0.76 
mL) and cooled to 0 °C. N-bromosuccinamide (70 mg, 0.392 mmol) was then added. 
The solution was stirred at 0 °C for 30 min, then saturated aqueous Na2S2O3 was added. 
The organics were washed with 10 % aqueous NH4OH, then saturated aqueous NH4Cl. 
The organics were then dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash chromatography (50:1 = hex:EtOAc) affording vinyl bromide (–)-3.35 (17 
mg, 19%) as a white solid. 
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Diol S3.5: 
Vinyl bromide (–)-3.35 (32 mg, 0.056 mmol) was dissolved in 1.3 mL THF. To this 
solution was added. TBAF (1.02 mL, 1.0 M in THF, 1.02 mmol) was then added. The 
solution was heated at 50 °C for 8 hours. The reaction mixture was then concentrated in 
vacuo. The residue was purified by flash chromatography (2:1 = hex:EtOAc) affording 
diol S3.5 (23 mg, 99%) as an oil. 1H NMR (500 MHz, CDCl3): δ  5.82 (dd, J = 2.9, 1.9 Hz, 
1H), 3.69 (d, J = 10.5 Hz, 1H), 3.64-3.61 (m, 1H), 3.40 (d, J = 10.5 Hz, 1H), 2.70-2.67 
(m, 1H), 2.36 (dt, J = 13.5, 3.5 Hz, 1H), 2.28-2.23 (m, 1H), 2.06 (ddd, J = 15.0, 6.6, 3.1 
Hz, 1H), 1.87 (ddd, J = 15.0, 11.2, 1.8 Hz, 1H), 1.72-1.65 (m, 3H), 1.57-1.48 (m, 4H), 
1.40-1.33 (m, 3H), 1.12 (s, 3H), 0.95 (s, 3H), 0.88 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 
133.12, 132.67, 75.97, 71.29, 44.05, 42.73, 41.38, 33.77, 30.37, 27.34, 25.25, 23.18, 
20.70, 17.87, 12.67, 11.24; HRMS (ESI): Calcd for (M+Na)+: 365.1194. Found m/z: 
365.1198. IR (thin film, neat): 3356 (br m), 2936 (s), 1586 (w), 1450 (w), 1377 (w), 1079 
(w), 1040 (w), 911 (w), 733 (w) cm–1;  = –13° (c = 1.33, CDCl3). 
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Aldehyde S3.6: 
Diol S.5 (12 mg, 0.035 mmol) and bis(acetoxy)iodobenzene (14 mg, 0.042 mmol) were 
dissolved in 0.35 mL of CH2Cl2. A single crystal of TEMPO was added. The reaction was 
allowed to stir at room temperature for 5 hrs. The reaction was then quenched with 
saturated aqueous Na2SO3. The aqueous layer was extracted with CH2Cl2, dried over 
MgSO4 and concentrated in vacuo. MPLC purification (4:1 = hex:EtOAc) gave 10 mg (83 
%) of an oil. 1H NMR (500 MHz, CDCl3): δ 5.84 (dd, J = 3.1, 1.8 Hz, 1H), 3.74 (dd, J = 
11.4, 4.7 Hz, 1H), 2.41 (dt, J = 13.6, 3.5 Hz, 1H), 2.29-2.23 (m, 1H), 2.08 (ddd, J = 15.0, 
6.6, 3.1 Hz, 1H), 1.93-1.87 (m, 2H), 1.83-1.79 (m, 1H), 1.75-1.72 (m, 1H), 1.66-1.62 (m, 
1H), 1.60-1.56 (m, 2H), 1.49-1.44 (m, 3H), 1.13 (s, 3H), 1.09 (s, 3H), 1.00 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ  206.66, 132.76, 132.52, 71.98, 57.22, 55.57, 44.22, 40.60, 
39.36, 33.77, 30.33, 26.66, 25.79, 25.05, 17.67, 12.70, 8.46; HRMS (ESI): Calcd for 
(M+Na)+: 363.0936. Found m/z: 363.0947. IR (thin film, neat): 3436 (br m), 2938 (s), 
2863 (m), 1725 (s), 1449 (w), 1081 (w), 1035 (w), 975 (w), 914 (w), 732 (w) cm–1;  
= –28° (c = 2.2, CDCl3). 
 
 
 
 
 
OH
Me Me
H
H
MeBr
H
O
€ 
α[ ]D
24
! 120!
 
 
TES Ether (–)-3.30: 
Alehyde S3.6 (15 mg, 0.046 mmol) was dissolved in 0.9 mL of CH2Cl2 and cooled to 0 
°C. 2,6-Lutidine (0.054 mL, 0.46 mmol) was added followed by TESOTf (0.052 mL, 0.23 
mmol) and the solution was allowed to warm to room temperature over 30 min. 
Saturated aqueous NaHCO3 was then added and the aqueous layer extracted with 
EtOAc. 1H NMR (500 MHz, CDCl3): δ 9.30 (s, 1H), 5.83 (dd, J = 2.9, 1.8 Hz, 1H), 3.76 
(dd, J = 11.2, 5.0 Hz, 1H), 2.36 (dt, J = 13.6, 3.5 Hz, 1H), 2.27-2.22 (m, 1H), 2.07 (ddd, J 
= 15.0, 6.6, 3.1 Hz, 1H), 1.91-1.83 (m, 2H), 1.77-1.68 (m, 2H), 1.62-1.48 (m, 3H), 1.43-
1.40 (m, 2H), 1.12 (s, 3H), 1.08 (s, 3H), 1.00 (s, 3H), 0.92 (s, 9H), 0.53 (qd, J = 7.9, 3.8 
Hz, 6H); 13C NMR (125 MHz, CDCl3): δ  207.19, 132.76, 132.67, 73.48, 57.28, 56.33, 
44.24, 40.24, 39.26, 33.79, 30.40, 27.33, 25.68, 25.10, 17.72, 12.72, 9.06, 6.95, 5.24; 
HRMS (ESI): Not Determined; IR (thin film, neat): Not Determined;  = –46.2 (c = 
0.31, CDCl3). 
 
 
 
Phosphonate 3.38: 
2-Bromopropionate (20.0 g, 120 mmol) was dissolved in 300 mL of acetonitrile. 
Triphenylphosphine (28.3 g, 108 mmol) was then added. The solution was warmed to 60 
°C overnight. The solution was then cooled to room temperature. Glyoxylic acid 
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monohydrate (9.9 g, 108 mmol) was then added followed by the addition of 
diisopropylethylamine (18.8 mL, 108 mmol). The solution was then stirred overnight at 
room temperature. The reaction mixture was diluted with EtOAc then washed 5 times 
with saturated aqueous NaHCO3. The aqueous layer was then acidified with conc. HCl 
and extracted three times with EtOAc. The organic layers were dried over MgSO4 and 
concentrated in vacuo to give 9.0 g of acid 3.42 as a yellow solid.  
 
The crude acid 3.42 (9.0 g, 62.4 mmol) was then dissolved in 250 mL of THF and cooled 
to 0 °C. Borane•THF complex  (62.4 mL, 1M in THF) was then added slowly. The 
reaction mixture was then warmed to room temperature and stirred overnight. To the 
light yellow reaction mixture, 20 mL of MeOH was added and then the reaction was 
stirred for 3 hours. The solution was then diluted with EtOAc and saturated aqueous 
NaHCO3. The aqueous layer was extracted with EtOAc, the combined organic layers 
were dried over Na2SO4, then concentrated in vacuo to give 6.2 g of alcohol 3.43 as a 
yellow oil. 
 
The cude alcohol 3.43 was then dissolved in 460 mL of CH2Cl2. Carbon tetrabromide 
(16.8 g, 50.7 mmol) followed by triphenylphosphine (13.3 g, 50.7 mmol) were then 
added to generate an orange/red solution. The solution was stirred for 5 hours, then 
quenched with saturated aqueous Na2SO3. The aqueous layer was extracted with 
CH2Cl2, then dried over Na2SO4 and concentrated in vacuo. The resulting solid was then 
dissolved in (10:1 = hex:EtOAc) and filtered through a pad of silica gel, then 
concentrated in vacuo to give 7.9 g of bromide 3.44 as an oil.  
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Bromide 3.44 (7.9 g, 40.9 mmol) was then dissolved in 8.0 mL of trimethylphosphite. The 
solution was heated to reflux overnight. The flask was then fitted with a short-path 
distillation head and the excess trimethyl phosphite was distilled away from phosphonate 
3.38 at 140 °C. Vacuum distilliation at 3 torr collecting ate 114 °C-118 °C gave 2.8 g 
(10.5 % from 2-bromopropionate) phosphonate 3.38 as a clear liquid. 1H NMR (500 
MHz, CDCl3): δ  6.75 (q, J = 7.8 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 9H), 2.80-2.74 (m, 2H), 
1.90 (d, J = 4.3 Hz, 3H).  
 
 
 
Bromide 3.49: 
Potassium bromide (202 mg, 1.7 mmol) and potassium fluoride (25 mg, 0.43 mmol) were 
flame dried  in a vial and triflate 3.48 (0.5 g, 0.85 mmol) in dioxane (4.5 mL, degassed by 
sparging with Ar for 30 min) was added. Separately, Pd2dba3 (47 mg, 0.05 mmol) and t-
BuXPhos (64 mg, 0.15 mmol) were dissolved in dioxine (4.0 mL, degassed by sparging 
with Ar for 30 min) and heated to 120 °C for 3 min to generate a red/orange solution. 
The palladium solution was then cannulated into the vial with the triflate. The vial was 
sealed with a Teflon® lined cap and solution was heated to 125 °C for 18 hours. The 
suspension was then diluted with hexanes and 0.5M HCl and the aqueous layer 
extracted with EtOAc. The combined organic layers were dried over MgSO4 and 
concentrated in vacuo. The residue was purified by flash chromatography (50:1 = 
hex:EtOAc) affording 3.49 (293 mg, 70%) as a white solid. 1H NMR (500 MHz, CDCl3): 
5.87 (t, J = 3.8 Hz, 1H), 3.75 (dd, J = 11.2, 5.4 Hz, 1H), 3.42 (d, J = 9.8 Hz, 1H), 3.19 (d, 
J = 9.7 Hz, 1H), 2.08-2.03 (m, 2H), 1.88-1.83 (m, 2H), 1.66-1.58 (m, 3H), 1.56 (s, 3H), 
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1.48-1.40 (m, 1H), 1.28-1.23 (m, 2H), 1.13 (s, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.62 (s, 
3H), 0.04 (dd, J = 9.2, 6.8 Hz, 12H). 
 
 
 
 
Diol 3.50: 
TBS ether 3.49 (293 mg, 0.57 mmol) was dissolved in THF (3.4 mL) and TBAF (3.4 mL, 
1.0M in THF, 3.40 mmol) was then added. The solution was heated at 50 °C for 6 hours, 
then cooled to room temperature and diluted with EtOAc and brine. The aqueous layer 
was extracted with EtOAc, the combined organics were dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by flash chromatography (1:1 = 
hex:EtOAc) affording 3.50 (144 mg, 88%) as an oil. 1H NMR (500 MHz, CDCl3): δ  5.88 
(dd, J = 4.8, 2.9 Hz, 1H), 3.73 (d, J = 10.4 Hz, 1H), 3.69 (dd, J = 11.7, 4.8 Hz, 1H), 3.44 
(d, J = 10.4 Hz, 1H), 2.86 (br s, 2H), 2.14-2.05 (m, 2H), 1.94 (dt, J = 13.4, 3.6 Hz, 1H), 
1.77-1.73 (m, 1H), 1.65-1.49 (m, 4H), 1.36-1.30 (m, 1H), 1.15 (s, 3H), 0.90 (s, 3H). 
 
 
 
Aldehyde 3.51: 
Diol 3.50 (140 mg, 0.48 mmol) and bis(acetoxy)iodobenzene (187 mg, 0.58 mmol) were 
dissolved in CH2Cl2 (5.0 mL). TEMPO (15 mg, 0.10 mmol) was then added and the 
solution was stirred for 4 hours. The reaction was then quenched with saturated 
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aqueous Na2S2O3, then extracted with CH2Cl2, dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash chromatography (5:1 = hex:EtOAc) affording 
3.51 (120 mg, 86%) as an oil. 1H NMR (500 MHz, CDCl3): δ  9.42 (s, 1H), 5.91 (t, J = 4.0 
Hz, 1H), 3.86-3.82 (m, 1H), 2.13-2.09 (m, 2H), 2.00 (dt, J = 13.6, 3.5 Hz, 1H), 1.90-1.86 
(m, 2H), 1.74-1.65 (m, 3H), 1.53-1.51 (m, 1H), 1.44-1.39 (m, 1H), 1.16 (s, 3H), 1.12 (s, 
3H). 
 
 
 
TES Ether 3.52: 
Aldehyde 3.51 (120 mg, 0.42 mmol) and 2,6-lutidine (0.73 mL, 6.27 mmol) were 
dissolved in CH2Cl2 (8 mL). TESOTf (0.47 mL, 2.09 mmol) was then added and the 
solution was stirred at room temperature  for 1 hr. Saturated aqueous NaHCO3 was then 
added, the aqueous layer was extracted with EtOAc and the combined organic layers 
were washed with 1N HCl. The organics were then dried over MgSO4 and concentrated 
in vacuo. The residue was purified by flash chromatography (75:1 = hex:EtOAc) 
affording TES ether 3.53 (113 mg, 81%) as a white semi-solid. 1H NMR (500 MHz, 
CDCl3): δ  9.35 (s, 1H), 5.88 (t, J = 3.9 Hz, 1H), 3.86 (dd, J = 10.5, 5.7 Hz, 1H), 2.09-
2.05 (m, 2H), 1.95 (dt, J = 13.5, 3.6 Hz, 1H), 1.85 (dd, J = 12.7, 1.8 Hz, 1H), 1.75-1.72 
(m, 2H), 1.63-1.58 (m, 1H), 1.39 (dt, J = 12.9, 6.5 Hz, 1H), 1.15 (s, 3H), 1.10 (s, 3H), 
0.92 (t, J = 7.9 Hz, 9H), 0.53 (qd, J = 8.1, 3.5 Hz, 6H). 
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Dienoate 3.53: 
Phosphonate 3.38 (278 mg, 1.25 mmol) was dissolved in 0.5 mL of THF then cooled to 0 
°C. To the solution, n-BuLi solution (0.52 mL, 2.5M in hex, 1.25 mmol) was added slowly 
with vigorous stirring. To the light yellow solution, aldehyde 3.52 (17 mg, 0.042 mmol) in 
0.5 mL THF was added. The solution was allowed to warm to room temperature and 
stirred for 12 hours. The reaction was quenched with brine and the aqueous layers were 
extracted with Et2O. The combined organics were dried over Na2SO4, then concentrated 
in vacuo. MPLC purification (40:1 = hex:EtOAc) gave 19 mg (91 %) of dienoate 3.53 as 
an oil. 1H NMR (500 MHz, CDCl3): δ  7.21-7.19 (m, 1H), 6.31 (dd, J = 15.3, 11.2 Hz, 1H), 
5.87 (dd, J = 4.8, 2.8 Hz, 1H), 5.75 (d, J = 15.3 Hz, 1H), 3.77 (s, 3H), 3.42 (t, J = 8.0 Hz, 
1H), 2.10-2.00 (m, 2H), 1.95 (d, J = 1.2 Hz, 3H), 1.94-1.90 (m, 1H), 1.71-1.67 (m, 2H), 
1.51-1.44 (m, 3H), 1.39-1.32 (m, 1H), 1.16 (s, 3H), 1.04 (s, 3H), 0.89 (t, J = 7.9 Hz, 9H), 
0.49 (dq, J = 15.9, 7.9 Hz, 6H); 13C-NMR (125 MHz, CDCl3): δ  169.30, 153.08, 139.00, 
136.50, 128.26, 125.47, 125.26, 77.36, 51.94, 50.14, 47.43, 41.07, 37.18, 28.93, 28.28, 
20.08, 19.81, 12.80, 12.12, 7.04, 5.22. 
 
 
 
Alcohol 3.54: 
Dienoate 3.53 (5 mg, 0.01 mmol) was dissolved in THF (0.1 mL) in a vial and TBAF 
(0.05 mL, 1.0M in THF, 0.05 mmol) added. The vial was sealed with a Teflon® lined cap 
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and heated to 50 °C for 30 min. The solvent was then removed in vacuo. The residue 
was purified by flash chromatography (15:1 = hex:EtOAc) affording alcohol 3.54 (3 mg, 
78 %) as an oil. 1H NMR (500 MHz, CDCl3): δ  7.23 (d, J = 11.0 Hz, 1H), 6.45-6.40 (m, 
1H), 5.88 (dd, J = 4.9, 2.7 Hz, 1H), 5.81 (d, J = 14.6 Hz, 1H), 3.77 (s, 3H), 3.44 (dd, J = 
11.5, 4.3 Hz, 1H), 2.09-1.99 (m, 2H), 1.98 (s, 3H), 1.86-1.82 (m, 1H), 1.69-1.66 (m, 1H), 
1.49-1.45 (m, 2H), 1.44-1.36 (m, 2H), 1.18 (s, 3H), 1.07 (s, 3H).  
 
 
 
 
Acid 3.55: 
Ester 3.54 (3 mg, 0.008 mmol) and LiOH (0.6 mL, 1.0M in H2O, 0.6 mmol) were 
dissolved in THF (0.6 mL) and MeOH (1.2 mL). The solution was stirred for 2 days. 
Once the starting ester had been consumed by TLC, the reaction was diluted with EtOAc 
and 1N HCl. The aqueous layer was then extracted with EtOAc. The organics were dried 
over Na2SO4 and concentrated in vacuo. The residue was purified by flash 
chromatography (1:1 = hex:EtOAc) affording 3.55 (1 mg) as an oil. The small amount of 
material made 1H NMR analysis difficult, but the spectrum clearly showed that the methyl 
ether had been hydrolyzed and the dienoate side-chain intact. The identity of 3.55 was 
confirmed by HRMS. HRMS (ESI): Calcd for (M–H)–: 367.0987. Found m/z: 367.0984. 
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Dienoate (–)-3.26:.  
Phosphonate 3.38 (147 mg, 0.66 mmol) was dissolved in 0.5 mL of THF then cooled to 0 
°C. To the solution, n-BuLi solution (0.26 mL, 2.5M in hex, 0.66 mmol) was added slowly 
with vigorous stirring. To the light yellow solution, aldehyde (–)-3.30 in 0.1 mL THF was 
added. The solution was allowed to warm to room temperature and stirred for 12 hours. 
The reaction was quenched with brine and the aqueous layer was extracted with EtOAc. 
The combined organic layers were dried over Na2SO4, then concentrated in vacuo. 
MPLC purification (50:1 = hex:EtOAc) gave 5 mg (82 % brsm) dienoate 3.26  as an oil 
and 5 mg of starting aldehyde 3.30. 1H NMR (500 MHz, CDCl3): δ  7.20 (d, J = 11.4 Hz, 
1H), 6.75 (q, J = 7.7 Hz, 1H), 6.24 (dd, J = 15.2, 11.4 Hz, 1H), 5.78 (t, J = 21.2 Hz, 2H), 
3.78 (s, 3H), 3.32 (dd, J = 11.8, 5.1 Hz, 1H), 2.80-2.73 (m, 2H), 2.34 (dt, J = 13.3, 3.1 
Hz, 1H), 2.25-2.23 (m, 1H), 2.07-2.03 (m, 1H), 1.91-1.84 (m, 4H), 1.75-1.70 (m, 1H), 
1.58 (s, 3H), 1.52-1.40 (m, 3H), 1.35-1.30 (m, 2H), 1.26 (d, J = 0.1 Hz, 3H), 1.13-1.12 
(m, 2H), 1.05-1.01 (m, 3H), 0.99-0.95 (m, 3H), 0.92-0.86 (m, 9H), 0.55-0.42 (m, 6H).; 
 = –57.2 (c = 0.08, CDCl3). 
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Iodoaniline 4.15:   
Aniline (515 mg, 1.89 mmol), CaCO3 (569 mg, 5.68 mmol), 1.0 mL of methanol, and 2.7 
mL of CH2Cl2 added to a flask. Benzyltrimethylammonium dichloroiodate (723mg, 2.08 
mmol) was then added, giving a green suspension. The reaction mixture was stirred 
overnight at room temperature to give a dark red suspension.  The reaction was then 
diluted with dichlormethane and saturated NaHCO3. The layers were separated and the 
aqueous layer was extracted with dichloromethane (3x). The combined organic layers 
were washed with a saturated sodium thiosulfate solution. The organic layer was dried 
over MgSO4, filtered and concentrated. The dark brown oil was purified by flash 
chromatography (8:1 = hex:EtOAc) to give 606 mg of a tan amorphous solid (81%). 1H 
NMR (500 MHz, CDCl3) δ  7.60 (s, 1H), 6.97 (s, 1H), 4.52 (d, J = 0.8 Hz, 2H), 0.98 (s, 
9H), 0.15 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 143.10, 143.10, 142.44, 142.44, 137.99, 
137.99, 118.48, 118.48, 114.74, 114.74, 79.51, 79.51, 68.86, 68.86, 26.13, 26.13, 18.56, 
18.56, -5.15, -5.15; IR (film) 3389, 2953, 2928, 2856, 1613, 1470, 1402, 1256, 1169, 
1102, 837, 778; HRMS (ESI) calcd. For (M+H)+: 398.0204. Found m/z: 398.0211 
 
 
 
Phthalamide 4.16:  
Iodoaniline 4.15 (2.73 g, 6.9 mmol), phthalic anhydride (2.95 g, 20.0 mmol), and 
triethylamine (2.9 mL, 20.7 mmol) were dissolved in 13.7 mL of PhMe. The solution was 
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brought to reflux for 12 hours. The solution was cooled to room temperature, then diluted 
with EtOAc and 1N HCl. The aqueous layer was extracted with EtOAc, dried over 
MgSO4 and concentrated in vacuo. The residue was purified by flash chromatography 
(8:1 = hex:EtOAc) affording 4.16 (2.7 g, 74%) as a yellow amorphous solid. 1H NMR 
(500 MHz, CDCl3) δ 7.99 (dd, J = 5.7, 3.0 Hz, 3H), 7.83 (dd, J = 5.6, 3.5 Hz, 2H), 7.46 (s, 
1H), 4.62 (s, 2H), 0.94 (s, 9H), 0.14 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 166.49, 
143.66, 139.53, 134.64, 132.09, 132.01, 130.01, 129.13, 124.19, 96.26, 68.85, 26.09, 
18.54, -5.17; IR(film) 2928 (w), 1727 (s), 1552 (w), 1468 (w), 1389 (w), 1106 (w), 837 
(w); HRMS (ESI) calcd. For(M+Na)+: 550.0078. Found m/z: 550.067 
 
 
 
Benzyl alcohol 4.17:  
Silylated benzyl acohol 4.16 (2.7 g, 5.1 mmol) was dissolved in 8.2 mL of THF, then 2.9 
mL 1N HCl was added. The solution was stirred for 3 hrs. It was then diluted with EtOAc 
and quenched with sat. NaHCO3 solution. The layers were separated and the aqueous 
layer was extracted 3 times with EtOAc. The combined organic layers were dried over 
MgSO4, filtered and then concentrated. The solids were taken up in 1:1 Hex:EtOAc, then 
heated until all solids were dissolved. Hexanes were  then added until a cloudy 
precipitate was formed. The suspension was placed in the freezer for 1 hour then filtered 
and washed with hexanes to give 1.65 g of a pale yellow semi-solid (79%). 1H NMR (500 
MHz, CDCl3) δ 8.01 (s, 1H), 7.96 (dd, J = 5.5, 3.0 Hz, 1H), 7.96 (dd, J = 5.5, 3.0 Hz, 2H), 
7.81 (dd, J = 5.5, 3.0 Hz, 1H), 7.81 (dd, J = 5.5, 3.0 Hz, 2H), 7.47 (s, ), 7.47 (d, J = 0.7 
Hz, 1H), 4.63 (s, 1H), 4.63 (s, 2H), 2.49 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 166.52, 
Cl
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143.37, 139.92, 134.74, 132.50, 131.90, 130.04, 129.29, 124.19, 97.26, 68.32; IR (film) 
3481 (br w), 1722 (s), 1468 (m), 1399 (m), 1054 (w), 874 (w), 719 (m) cm-1; HRMS (ESI) 
calcd. for (M+Na)+: 435.9213 Found m/z: 435.9216. 
 
  
 
 
Bromide 4.9:  
Alcohol 4.17 (1.65 g, 3.99 mmol) and carbon tetrabromide (1.59 g, 4.79 mmol) were 
dissolved in 66.5 mL of CH2Cl2. Triphenylphosphine (1.26 g, 4.79 mmol) was then added 
and the solution was stirred overnight. CH2Cl2 was removed in vacuo. The crude 
reaction mixture was purified via flash chromatography (4:1 = hex:EtOAc) to give 1.74 g 
(92 %) of a pale yellow solid. 1H NMR (500 MHz, CDCl3) 8.08 (s, 1H), 7.99 (dd, J = 5.4, 
3.2 Hz, 2H), 7.84 (dd, J = 5.5, 3.1 Hz, 2H), 7.46 (s, 1H), 4.58 (s, 2H); 13C NMR (125 
MHz, CDCl3) δ 166.22, 141.08, 140.48, 134.84, 131.90, 131.75, 124.27, 36.84; IR (film) 
3487 (w), 3098 (w), 3027 (w), 1723 (s), 1469 (m), 1399 (m), 1083 (w), 876 (m), 717 (m); 
HRMS (ESI) calcd. for (M+H)+: 475.8472 Found m/z: 475.847 
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Hydrazone (+)-4.8:  
All glassware was base-bathed prior to use. The cleaned glassware was rinse 3 times 
with deionized water then acetone before flame drying. Hydrazone (96 mg, 0.359 mmol) 
was azeotroped 3 times with PhH then diluted with 1.6 mL of THF. The solution was 
cooled to –78 °C and 0.31 mL of t-Butyllithium solution (0.43 mmol, 1.4M in Hex) was 
added. The solution was stirred at –78° C for 2 hours. The anion solution was cooled to 
–100 °C and benzyl bromide 4.9 (188 mg, 0.395 mmol) in 1.6 mL THF was added 
dropwise over 30 min. The orange solution was stirred at –100 °C for  another 30 min, 
then warmed to –78 °C for 2 hours. 0.5 mL of saturated NH4Cl solution was added at  –
78 °C, then the solution was warmed slowly to room temperature. 1 mL of brine was 
added and aqueous layer was extracted 3 times with EtOAc. The organic layer was then 
dried over Na2SO4. MPLC purification using 2:1 hexanes:EtOAc game 141 mg white 
foam (60%). 1H NMR (500 MHz, CDCl3) δ 7.99 (s, 1H), 7.97 (dd, J = 4.2, 2.3 Hz, 2H), 
7.81 (dd, J = 5.3, 3.1 Hz, 2H), 7.54 (s, 1H), 3.21 (dd, J = 13.3, 11.1 Hz, 1H), 3.02 (d, J = 
10.8 Hz, 1H), 2.56 (dd, J = 20.3, 13.0 Hz, 2H), 2.30 (d, J = 12.4 Hz, 1H), 1.62 (s, 3H), 
1.37 (s, 3H), 1.25 (s, 3H), 1.21 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 208.48, 166.47, 
166.32, 142.88, 140.24, 134.66, 134.64, 133.60, 131.97, 131.49, 129.43, 124.17, 
124.11, 101.23, 81.40, 77.48, 59.34, 54.29, 35.33, 33.56, 32.07, 28.78, 24.75;  IR (film) 
2970 (m), 2922 (m), 1727 (s), 1466 (m), 1397 (m), 1228 (w), 1108 (m), 719 (m) cm-1; 
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HRMS (ESI) calcd. for (M+H)+: 664.1439 Found m/z: 664.1439  = +93° (c = 3.53, 
CDCl3). 
 
 
 
Ketone (–)-4.18:   
 Hydrazone (+)-4.8 (141mg, 0.212 mmol), 2.3 mL of MeOH, 0.80 mL of pH 7 buffer and 
0.51 mL of THF added to a vial. Selenium dioxide (19 mg, 0.17 mmol) was then added, 
followed by 0.21 mL of 30% hydrogen peroxide solution. The vial was capped and stirred 
overnight. The reaction was diluted with EtOAc and washed with sat. NaHCO3. The 
aqueous layer was extracted with EtOAc (3x). The organic layer was dried over sodium 
sulfate, and then concentrated. MPLC purification using 5:1 hexanes:EtOAc gave 56 mg 
of a semi-solid (50%) 1H NMR (500 MHz, CDCl3) 7.99-7.95 (m, 3H), 7.81 (dd, J = 5.2, 
3.0 Hz, 2H), 7.53 (s, 1H), 3.21 (t, J = 12.3 Hz, 1H), 3.02 (d, J = 10.8 Hz, 1H), 2.56 (dd, J 
= 23.0, 13.1 Hz, 2H), 2.30 (d, J = 12.4 Hz, 1H), 1.61 (s, 3H), 1.37 (s, 3H), 1.24 (s, 3H), 
1.20 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 208.49, 166.48, 166.32, 142.88, 140.24, 
134.66, 134.64, 133.58, 131.96, 131.49, 129.44, 124.17, 124.11, 101.22, 81.39, 59.35, 
54.28, 35.33, 33.55, 32.07, 28.80, 24.75; IR (film) 2975 (w), 1784 (s), 1466 (m), 1399 
(m), 1226 (w), 1109 (w), 719 (m) cm-1; HRMS (ESI) calcd. for (M+Na)+: 574.0258 Found 
m/z: 574.0260;  = –159° (c = 2.52, CDCl3). 
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Triflate (+)-4.19:  
Ketone (–)-3.18 (40 mg, 0.072 mmol) and phenyltriflamide (128  mg, 0.36 mmol) were 
dissolved in 2.0 mL of THF. The solution was cooled to –78 °C and 0.36 mL lithium 
hexamethyldisilazane (1.0M in THF) was added and the reaction was stirred for 1 hr. At 
The reaction was quenched with pH 7 buffer at –78 °C and then was allowed to warm to 
room temperature. The aqueous layer was extracted with EtOAc, the combined organic 
layers dried over Na2SO4 and concentrated in vacuo. MPLC purification 4:1 (hex:EtOAc) 
gave 32 mg (65 %) of an oil. 1H NMR (500 MHz, CDCl3) δ 8.05 (s, 1H), 7.99-7.97 (m, 
2H), 7.82 (dd, J = 5.5, 3.1 Hz, 2H), 7.07 (s, 1H), 5.82 (s, 1H), 3.29 (dd, J = 13.1, 5.0 Hz, 
1H), 2.80 (t, J = 12.0 Hz, 1H), 2.70 (dd, J = 10.7, 5.0 Hz, 1H), 1.44 (s, 3H), 1.41 (s, 3H), 
1.39 (s, 3H), 1.38 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 166.32, 166.07, 146.94, 141.84, 
140.38, 134.66, 134.64, 132.08, 132.02, 131.96, 131.50, 130.11, 125.20, 124.19, 
124.16, 101.21, 77.36, 77.30, 77.23, 77.10, 75.90, 72.85, 46.23, 40.98, 31.92, 28.60, 
28.45, 27.78; IR (film) 2920 (s), 2850 (m), 1727 (s), 1466 (m), 1399 (m), 1210 (m), 1138 
(m), 718 (m) cm-1;  HRMS (ESI) calcd. for (M+H)+: 682.9853 Found m/z: 682.9871;  
= –26.6° (c = 0.52, CDCl3). 
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Phthalimide 4.20:  
Dioxane was first degassed by sparging with Ar for at least 30 min. Lithium chloride (79 
mg, 1.87 mmol) was added to a vial and flame dried three times. Triflate 4.19 in 1 mL of 
benzene was added to the vial and then the benzene was removed in vacuo. Pd(PPh3)4 
(22 mg, 0.019 mmol) was then added to the vial and the vial was purged with Ar. 
Dioxane (1.1 mL) was then added followed by hexamethyl ditin (23 µL, 0.112 mmol). 
The vial was capped and heated at 100 °C for 18 hours. Once the reaction had been 
cooled to room temperature, the suspension was diluted with EtOAc and was stirred with 
KF on Celite for 2 hours. The susupension was filtered and concentrated in vacuo. 
MPLC purification (5:1 = hex:EtoAc) gave 31 mg (82 %) of a white semi-solid. 1H NMR 
(500 MHz, CDCl3) δ 7.98 (dd, J = 5.4, 3.1 Hz, 2H), 7.82 (dd, J = 5.5, 3.1 Hz, 2H), 7.60 (s, 
1H), 7.23 (s, 1H), 6.11 (d, J = 3.1 Hz, 1H), 3.10 (dd, J = 16.5, 9.4 Hz, 1H), 2.96 (ddd, J = 
9.4, 7.6, 3.0 Hz, 1H), 2.66 (dd, J = 16.3, 7.4 Hz, 1H), 1.38 (s, 3H), 1.35 (s, 3H), 1.34 (s, 
3H), 1.11 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 167.09, 166.94, 144.38, 143.10, 137.49, 
134.61, 134.60, 132.07, 131.87, 128.66, 127.37, 125.52, 124.09, 122.26, 74.44, 72.78, 
48.58, 33.27, 31.61, 30.03, 29.80, 22.35; IR(film) Not Determined;  = Not 
Determined 
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Aniline (–)-4.2:  
Phthalimide 4.20 (31 mg, 0.076 mmol) and hydrazine hydrate (36 µL, 0.114 mmol) were 
dissolved in 4.5 mL of EtOH. After stirring for 24 hours, the cloudy suspension was 
filtered and concentrated in vacuo. MPLC purification (5:1  = hex:EtOAc) gave 11 mg 
(49%) as an oil 1H NMR (500 MHz, C6D6) δ 7.41 (s, 1H), 6.20 (s, 1H), 5.66 (d, J = 3.0 
Hz, 1H), 3.53 (s, 2H), 2.85 (ddd, J = 9.3, 7.7, 2.9 Hz, 1H), 2.67 (dd, J = 16.2, 9.3 Hz, 
1H), 2.35 (dd, J = 16.7, 7.0 Hz, 1H), 1.49 (s, 3H), 1.44 (s, 3H), 1.41 (s, 3H), 1.11 (s, 3H); 
13C NMR (125 MHz, C6D6)  δ  145.51, 143.99, 138.95, 132.46, 122.56, 120.66, 118.96, 
112.31, 74.64, 73.10, 49.53, 33.93, 32.77, 30.92, 30.81, 22.82; IR (film) 2947 (m), 1472 
(m), 1376 (m), 1227 (s), 1195 (s), 1143 (s), 989 (w); HRMS (ESI) calcd. for (M+H)+: 
278.1312 Found m/z: 278.1311;  = –11.4° (c = 0.6, CDCl3). 
 
 
 
Indole 5.7: 
Indoline 5.9 (93 µL, 0.25M in C6D6, 0.023 mmol) was transferred to a vial and the C6D6 
was removed in vacuo. Vinyl bromide 5.5 (24 mg, 0.070 mmol), Buchwald’s 1st 
generation RuPhos-Cl-Palladacycle precatalyst (16.9 mg, 0.023 mmol) and RuPhos 
(10.8 mg, 0.023 mmol) were added to the vial. The vial was then purged with Ar and 
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toulene (100 µL, degassed by sparging with Ar for 30 min) was added to the vial. 
Sodium t-butoxide (58 µL, 2.0M in THF) was added and the vial was sealed with a 
Teflon® lined cap. The reaction was heated at 120 °C for 18 hours, then cooled to room 
temperature. The suspension was diluted with 20:1 hex:EtOAc, filtered through a pad of 
silica gel and concentrated in vacuo. MPLC purification (60:1 = hex:EtOAc) gave 6.2 mg 
(37 %) of indole 5.7 as a semi-solid.  1H NMR (500 MHz, C6D6) δ 7.78 (s,1H), 6.92 (dd, J 
= 8.4, 2.5 Hz, 1H), 6.84 (d, J = 2.1 Hz, 1H), 6.49 (s, 1H), 6.14 (d, J = 3.2 Hz, 1H), 5.85 
(d, J = 3.7 Hz, 1H), 5.28 (d, J = 20.3 Hz, 2H), 5.00 (s, 1H), 3.54 (s, 3H), 3.33 (t, J = 3.4 
Hz, 1H), 2.89 (td, J = 13.5, 6.4 Hz, 3H), 2.58 (dd, J = 12.8, 11.2 Hz, 1H), 2.34 (t, J = 9.0 
Hz, 2H), 2.27-2.18 (m, 2H), 1.96 (dt, J = 27.7, 7.3 Hz, 3H), 1.88 (s, 3H), 1.84-1.69 (m, 
6H), 1.66 (s, 3H), 1.65 (s, 3H), 1.50 (s, 3H), 1.46-1.39 (m, 7H), 1.33 (s, 4H), 1.32 (s, 3H), 
1.31 (s, 3H), 1.31 (s, 3H), 1.29 (s, 3H), 1.23-1.22 (m, 1H), 1.11 (s, 3H), 1.03 (t, J = 8.0 
Hz, 9H), 0.76 (q, J = 7.9 Hz, 6H); 13C NMR (125 MHz, C6D6) δ 158.46, 154.14, 152.39, 
143.67, 138.11, 137.96, 135.41, 135.32, 132.80, 126.33, 122.88, 120.10, 114.38, 
110.11, 84.44, 79.18, 76.96, 74.60, 72.84, 70.20, 60.88, 59.32, 54.85, 44.80, 42.28, 
37.76, 35.06, 35.00, 34.89, 32.48, 31.98, 30.56, 30.26, 30.03, 27.84, 27.81, 26.59, 
26.22, 25.66, 23.06, 22.58, 22.49, 22.21, 20.90, 18.96, 18.63, 18.61, 18.58, 17.78, 
17.11, 14.35, 13.48, 11.67, 7.33, 7.17;  = +71.8° (c = 0.4, CDCl3). 
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Alcohol 5.8:  
TES etherl 5.7 (2 mg, 0.002 mmol) was dissolved in THF (1.5 mL) and cooled to 0 °C. 
TBAF (20 µL, 0.1M in THF, 0.002 mmol) was then added and the reaction was allowed 
to stir for 30 min. Brine was added and the aqueous layer was extracted with EtOAc. 
The organics were dried over MgSO4 and concentrated in vacuo to give ~0.8 mg of the 
entitled compound. 1H NMR analysis proved difficult, but TES group was no longer 
visible in the crude 1H NMR. The identity of alcohol 5.8 was confirmed by HRMS. HRMS 
(ESI) calcd. for (M+H)+: 762.4839 Found m/z: 762.4843 
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Appendix. Spectroscopic Data for Chapters 2, 3, 4, and 5 
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